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ABSTRACT
A STATISTICAL FRAMEWORK FOR DENOISING
SINGLE-CELL RNA SEQUENCING DATA
Mo Huang
Nancy R. Zhang
Single-cell RNA sequencing (scRNA-seq) is a powerful technique for quantifying the gene
expression in individual cells. The output of scRNA-seq is a gene expression matrix where
each entry is a count of the number of RNA molecules for a given gene in a cell. However,
the observed counts are noisy representations of true expression. Technical noise in scRNA-
seq experiments produces an observed expression matrix with low counts and an abundance
of zeros, resulting in a low signal to noise ratio. The motivation of this thesis is to develop
methods which remove the technical noise while preserving real biological signal. First,
we present SAVER, a statistical framework for modeling and denoising scRNA-seq data.
SAVER is able to recover the true expression without introducing artificial signal. Then,
we consider the problem of removing the effects of sequencing batch and other confounding
variables in dimension reduction and denoising of scRNA-seq data. By examining the linear
factor model with interactions, we show that a conditional variational autoencoder (CVAE)
with a weighted objective function can disentangle latent factors from observed covariates
by modeling the interaction effects through its nonlinear activation function. We develop
a method called SAVER-CVAE, which incorporates the weighted CVAE into the SAVER
framework, and demonstrate its ability to simultaneously perform dimension reduction and
denoising while adjusting for observed covariates in scRNA-seq data.
v
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CHAPTER 1 : Introduction
The turn of the 21th century brought about high-throughput DNA and RNA sequencing
technologies which allowed scientists to investigate the interplay between genetics and cellu-
lar function. The foundation of our understanding of cellular function is the central dogma
of biology. The central dogma of biology describes the transfer of biological information
between three main biopolymers: DNA, RNA, and protein. Information stored in specific
sequences of DNA called genes are transcribed into RNA molecules. Some of these genes
encode RNA molecules which are translated into proteins, which then go on to play impor-
tant roles in cellular functions such as cellular metabolism, DNA replication, and molecular
transport. Other genes encode RNA molecules which perform regulatory or processing roles.
Thus, gene expression is a major determinant of the functions of a cell.
The expression of a gene can be quantified by the number of RNA molecules that are
transcribed for that gene. High-throughput RNA sequencing (RNA-seq) is currently the
primary technology to profile gene expression in cells. RNA-seq was first applied to bulk
tissues, where the RNA molecules from each cell are combined and sequenced. This results
in the profiling of the average gene expression in the tissue. However, bulk RNA-seq fails to
capture the biological heterogeneity across cells in the same tissue. The first application of
RNA-seq to individual cells, called single-cell RNA-seq (scRNA-seq), was reported by Tang
et al. (2009). Tang et al. (2009) modified the bulk RNA-seq protocol to account for the
low starting amount of RNA in each cell. Only six single cells were analyzed in the study.
Technological advances over the last decade have increased the throughput of scRNA-seq
experiments to hundreds of thousands and even millions of cells in one experiment. scRNA-
seq has been implemented in a wide variety of research settings such as identifying novel
cell types (Cao et al. 2019; Keren-Shaul et al. 2017; Zeisel et al. 2015), profiling of whole
organisms (Cao et al. 2017; Regev et al. 2017; Schaum et al. 2018), and characterizing
drivers for disease (Azizi et al. 2018; Grubman et al. 2019; Patel et al. 2014).
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The growth of the size of scRNA-seq experiments is not without some drawbacks. Due to
the low total amount of RNA molecules in each individual cell, scRNA-seq data can be
extremely sparse. In addition, large-scale experiments usually make a trade-off between the
number of cells sequenced and the depth at which each cell is sequenced. A lower sequencing
depth per cell results in even sparser and noisier data. The main challenge in analyzing and
interpreting scRNA-seq data is separating the technical noise from true biological variation.
This thesis is based on the work of two papers which propose methods to remove technical
noise while preserving biological signal in scRNA-seq experiments. In the first paper, we
consider the problem of denoising the observed gene expression matrix from scRNA-seq
data. We propose an empirical Bayes framework for modeling and denoising scRNA-seq
data called SAVER (Huang et al. 2018). To denoise the data, we leverage the underlying
correlation structure found in the expression matrix due to biological gene relationships
and pathways. The SAVER framework allows for the borrowing of strength across multiple
genes to generate informative priors for the true expression distribution. Careful consid-
eration of gene prediction using cross-validated Lasso regression, as well as the shrinkage
properties of SAVER, allows for accurate gene expression recovery while minimizing the
risk of introducing artificial signal. We compare SAVER to other denoising methods in an
RNA FISH validation experiment and a data down-sampling experiment and discover that
the observed scRNA-seq data is a poor representation of true gene expression. Other de-
noising methods often exacerbate the problem. Furthermore, we evaluate the performance
of SAVER under various conditions such as number of cells, experiment capture efficiency,
and heterogeneity of the dataset. We also present neutral third party evaluations which
assessed the performance of competing methods. Finally, we consider the computational
aspects of the SAVER procedure. SAVER relies on performing nodewise cross-validated
Lasso regression to generate gene predictions. In speeding up the algorithm, we noticed
a strong relationship between the maximum absolute correlation and the penalty parame-
ter in the Lasso regression which gives the lowest cross validation error. We describe this
relationship in the context of nodewise Lasso regression and demonstrate its behavior in
2
simulation studies.
In the second paper, we address the issue of denoising and dimension reduction in the pres-
ence of observed technical covariates in scRNA-seq experiments. scRNA-seq experiments
often contain sample-level covariates such as sequencing batch or patient characteristics. In
addition, individual cells are affected by technical covariates such as library size and mito-
chondrial RNA content. Many methods for scRNA-seq batch correction have been proposed
but no existing method performs denoising and dimension reduction while simultaneously
adjusting for covariates beyond simply batch. First, we formulate a general model for in-
corporating observed covariates and unobserved latent factors. We propose a method called
α-CVAE, which is based on the conditional variational autoencoder. α-CVAE minimizes
a weighted objective function which encourages the observed covariates and unobserved
latent factors to explain separate sources of variation in the data. The weighted objective is
motivated by the correspondence between α-CVAE and constrained principal components
analysis (CPCA) in estimating a linear factor model. In the linear factor model with in-
teractions between the observed covariates and unobserved latent factors, α-CVAE is able
capture the interactions and remove the effects of the technical covariates while a linear
method like CPCA can not. We incorporate the α-CVAE into the SAVER framework and
developed a method called SAVER-CVAE which performs dimension reduction and de-
noising of scRNA-seq data while adjusting for observed covariates. Evaluations with other
scRNA-seq batch correction methods reveal that they do not effectively remove the effects
of batch from the gene expression matrix. Finally, we demonstrate the ability of SAVER-
CVAE to correct for observed covariates in an Alzheimer’s disease experiment where the
biological question of interest is confounded with batch.
3
CHAPTER 2 : SAVER: Gene Expression Recovery for Single-Cell RNA Sequencing
Joint work with Jingshu Wang, Eduardo Torre, Sydney Shaffer, Roberto Bonasio, John I.
Murray, Arjun Raj, Mingyao Li, and Nancy R. Zhang1
2.1. Introduction
Single-cell RNA sequencing (scRNA-seq) quantifies the gene expression level across all genes
in each cell in a sample of cells. The output is an expression matrix where each entry is
an integer count of the RNA molecules for a gene in a cell. The expression matrix can
then be used in downstream analyses such as characterizing different cell types through
visualization and clustering, identifying differentially expressed genes between groups of
cells, or discovering gene pathway networks.
One of the main challenges in analyzing scRNA-seq data is accounting for the technical
noise (Brennecke et al. 2013; Grün, Kester, and Oudenaarden 2014). In bulk RNA-seq,
the RNA molecules from the cells of a tissue sample are combined for sequencing and
quantification. This large pool of RNA molecules allows for accurate assessment of the
average transcriptional landscape of a tissue. However, it is unable to characterize the rich
variation that exists between cells. scRNA-seq gives us the ability to capture cell-to-cell
heterogeneity but at the cost of low signal due to the limited amount of RNA in each
individual cell. This leads to a sparse expression matrix where 80-95% of entries are zero
for a typical scRNA-seq experiment. In addition, most of the non-zero entries consist of
low count values which have low signal-to-noise ratio.
Methods for performing downstream analysis of scRNA-seq data either directly use the
observed counts (Butler et al. 2018; Stuart et al. 2019) or typically account for the noise
using zero-inflated models (Finak et al. 2015; Kharchenko, Silberstein, and Scadden 2014;
1M.H. and N.R.Z. conceived this work. M.H., with feedback from N.R.Z., and M.L., designed the model
and estimation algorithm, implemented the SAVER software, designed the in silico experiments, and led the
data analysis. J.W. validated the Poisson noise model in ERCC data. E.T., H.D., S.S., R.B., J.I.M., and
A.R. performed the RNA FISH and Drop-seq experiments for the melanoma cell line.
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Pierson and Yau 2015). Recently, methods for denoising and imputing the zero counts have
been developed (Dijk et al. 2018; Li and Li 2018). However, these methods lack statistical
interpretation and do not provide a measure of uncertainty for estimated values.
In this work, we present an empirical Bayes framework called SAVER (Single-cell Anal-
yses Via Expression Recovery) for denoising the observed scRNA-seq expression matrix
to recover the true expression levels (Huang et al. 2018). We leverage gene relationships
through the underlying correlation structure in the expression matrix to generative infor-
mative priors. The SAVER output is a posterior distribution which quantifies estimation
uncertainty. Through an RNA FISH experiment and a data down-sampling experiment,
we show that the observed scRNA-seq data is a poor representation of the true expression
levels and that applying SAVER helps recover the true expression profiles. In addition, we
show through our own experiments and also third party evaluations that SAVER does not
introduce false signals unlike other denoising/imputation methods. Finally, we investigate
an approximation to nodewise Lasso regression using the maximum absolute correlation.
SAVER is implemented in the R package SAVER on CRAN.
2.2. Related Works
Over the last three years, a myriad of methods have been developed to enhance the signal
in scRNA-seq datasets. These methods fall under two main categories: imputation and de-
noising. However, the terms “imputation” and “denoising” have been used interchangeably
at times in the single-cell literature to both mean removing technical variation while pre-
serving biological variation. In this section, we will clarify what we believe is the difference
between imputation and denoising and introduce existing methods that perform each.
The paper by Kharchenko, Silberstein, and Scadden (2014) was one of the first papers to
introduce the term “dropout” in the context of scRNA-seq. Dropout occurs when RNA
molecules for a gene are observed at moderate or high expression for one cell but not
expressed in another similar cell. Kharchenko, Silberstein, and Scadden (2014) noted that
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these dropouts could be the result of the technical noise of RNA molecules being “missed”
during the quantification procedure or from stochastic biological variability. The concept
of dropouts slowly permeated throughout the scRNA-seq field and led to the development
of zero-inflation models (Finak et al. 2015; Kharchenko, Silberstein, and Scadden 2014;
Pierson and Yau 2015) which sought to model the dropout.
Over time, dropouts were considered less the result of biological variation and more the
result of technical noise. The concept of dropouts shifted meaning to refer to only the
technical missingness of an RNA molecule. Some groups treated the dropouts as a missing
data problem and introduced the concept of imputing the dropout events to recover the
true expression.
One method for imputing dropout events is scImpute developed by Li and Li (2018). scIm-
pute first clusters cells into K clusters, where K is supplied by the user. Within each cluster,
a dropout probability is estimated for each gene and cell based on a Gamma-Normal mix-
ture distribution. If most cells in the cluster have high expression, then a zero count is likely
to be a dropout event, whereas if most cells in the cluster have low and variable expression,
then the zero count is likely to be biological. For each cell, a set of genes with low esti-
mated dropout probability is used to fit a non-negative least squares regression to identify a
linear combination of cells which are predictive of gene expression. The fitted regression is
then used to impute the values of the set of genes with high estimated dropout probability.
scImpute lacks a statistical model for the noise, which results in difficult interpretation, and
does not provide a measure of estimation uncertainty.
Over the years, the concept of dropouts and zero-inflation of scRNA-seq have come into
question. With advances in technology and better understanding of the noise structure in
scRNA-seq data, recent studies have shown that scRNA-seq data is not necessarily zero-
inflated and that the zeros are the result of Poisson sampling (Chen et al. 2018; Hafemeister
and Satija 2019; Kim et al. 2015; Svensson 2020; Wang et al. 2018b). In addition, all RNA
molecules are subject to the noise introduced in the experimental protocol so it does not
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make sense to denoise only the observed zero counts and not the non-zero counts. Thus,
we consider denoising, which removes technical noise for both zero and non-zero counts, to
be superior to dropout imputation.
One of the first methods for denoising was MAGIC developed by Dijk et al. (2018). MAGIC
is a data diffusion technique used to learn an underlying low-dimensional manifold which
captures cell phenotypes. It is a nearest-neighbors based approach where cell distances
are converted to a Markov matrix, which is then exponentiated to perform the diffusion.
The end result is a smoothed expression matrix. However, MAGIC tends to oversmooth
the data, lacks a statistical noise model, and does not provide a measure of estimation
uncertainty.
After the publication of SAVER, a variety of imputation and denoising methods have been
developed. Hou et al. (2020) gives an extensive evaluation of many of these methods. Here,
we would like to point out three deep learning methods in particular which have been
shown to perform well. Advantages of using deep learning methods include their flexibility
in modeling and their scalability to large datasets. However, deep learning methods often
come at the cost of reproducibility and interpretability.
One of the first deep learning methods for denoising scRNA-seq data was DCA developed
by Eraslan et al. (2019). DCA is an autoencoder network, which is a type of neural network
that compresses the high-dimensional data into a low-dimensional manifold and projects
the data back into the high-dimensional space. This is similar to low-rank matrix approx-
imation via SVD in the linear setting. DCA assumes a zero-inflated negative binomial
distribution. Another method called scVI, developed by Lopez et al. (2018), uses a vari-
ational autoencoder to perform the denoising. scVI also assumes a zero-inflated negative
binomial distribution. However, unlike DCA, scVI accounts for estimation uncertainty via
a posterior distribution.
Finally, a deep learning method for denoising called SAVER-X was developed by Wang et al.
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(2019). SAVER-X builds off the SAVER framework established in this chapter but uses an
autoencoder to generate the prior means. SAVER-X uses pretraining on existing datasets
for transfer learning, which has been shown to improve the performance of denoising.
2.3. Model
2.3.1. scRNA-seq Noise Model
First, we will give a brief overview of the biology behind scRNA-seq. scRNA-seq experi-
mental protocols begin with the extraction of the tissue of interest and dissociation of the
cells to isolate individual cells. The most commonly used scRNA-seq protocols capture
the cells in nanoliter droplets. The cells are then lysed within the droplets and the RNA
molecules are tagged with a cell-specific barcode and a molecule-specific sequence called a
unique molecule identifier (UMI). UMIs enable the tracking of individual RNA molecules
during the amplification and sequencing steps that follow. The RNA molecules are then con-
verted to the more stable cDNA through a step called reverse transcription and the cDNA
molecules are amplified and sequenced. Sequenced reads are mapped to specific genes and
an expression matrix of cells by genes is produced, where each entry is the number of the
UMIs for that specific gene and cell. Hwang, Lee, and Bang (2018) and Chen, Ning, and Shi
(2019) provide more detailed descriptions of recent scRNA-seq protocols. A major source
of the noise in scRNA-seq is the capture efficiency. The capture efficiency is the percentage
of original RNA molecules which are observed in the expression matrix. Typically, it can
vary between 1-20% depending on the sequencing technology and experimental protocol
(Svensson et al. 2017; Ziegenhain et al. 2017). Low capture efficiency results in a sparse
and low count expression matrix.
Let Ygc denote the UMI count of gene g on cell c. Ygc corresponds to the number of observed
RNA molecules. We model Ygc as a Poisson random variable
Ygc ∼ Poisson(scλgc), (2.1)
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where sc is the cell-specific normalization factor and λgc is the normalized true expression
in the cell. This noise model has been well-described in characterizing the noise distribution
of UMI-based scRNA-seq experiments. It was first proposed by Kim et al. (2015) in their
generative model for the quantification of single-cell gene expression. They verified the
model using External RNA Control Consortium (ERCC) spike-ins. ERCC spike-ins are
known concentrations of synthetic RNA molecules which are added prior to the reverse
transcription and sequencing steps. After sequencing, the number of sequenced ERCC
molecules is compared to the original concentration to measure the efficiency loss in the
experiment. In a later study, Wang et al. (2018b) verified the Poisson noise model for
scRNA-seq data by comparing the sampling distributions of nine UMI-based scRNA-seq
datasets containing ERCC spike-ins. They found that the technical noise of UMI counts is
simply Poisson after accounting for cell-to-cell variation through the normalization factor
sc.
The normalized true expression λgc is not known beforehand. In fact, λgc is the quantity
that we are trying to estimate. As a result, we place a gamma distribution on λgc such that
we now have the model
Ygc ∼ Poisson(scλgc)
λgc ∼ Gamma(αgc, βgc),
(2.2)
where αgc and βgc are the prior shape and rate parameters of the gamma distribution. The
gamma distribution is chosen for analytical convenience as it is a Bayesian conjugate prior
for the Poisson distribution. In addition, the Poisson-gamma distribution is also known as
the negative binomial distribution, another widely used model for single-cell RNA-seq data
(Grün, Kester, and Oudenaarden 2014; Hafemeister and Satija 2019) and bulk RNA-seq
data (Love, Huber, and Anders 2014; Robinson and Smyth 2007). However, instead of only
assuming a constant dispersion parameter, we let the dispersion parameter αgc be a flexible
function of the prior gamma mean. We will elaborate on this in the Section 2.3.2.
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The cell-specific normalization factor sc is typically not known either. It can be estimated in
one of two ways. The first is through the use of cell-specific ERCC spike-ins. By comparing
the known input concentration with the observed sequenced counts, we can derive a cell-
specific efficiency loss and use that as sc. sc in this case would be on the order of 1-20%
depending on the sequencing depth and efficiency. Thus, the magnitude of λgc would be
larger than the observed Ygc and the interpretation of λgc would be the number of original
RNA molecules. However, researchers are not as interested in the absolute total number
original RNA molecules as they are in the concentration of RNA molecules. As a result,
ERCC spike-ins are not typically used in scRNA-seq experiments. When the efficiency is
not estimable, the second way to estimate the normalization factor is simply through the
total number of RNA molecules sequenced in a cell, which is also known as the library size.
Since sequencing reads are allocated randomly, there exists variation in the total number
of reads allocated to each cell. By setting sc to the library size, or more typically a scaled
version of the library size, the interpretation of λgc becomes the concentration or relative
expression of RNA molecules in a cell. More advanced approaches to estimating scRNA-
seq normalizations factors have been developed (Bacher et al. 2017; Hafemeister and Satija
2019; Lun, Bach, and Marioni 2016; Vallejos, Marioni, and Richardson 2015) and can easily
be incorporated into this model.
2.3.2. SAVER Procedure
Given a data matrix Y and an estimate of s, we want to recover the posterior distribution
λ|Y. Unlike conventional Bayesian methods where prior distributions are placed on α
and β, we would like to produce informative priors for the parameters of the Gamma
distribution. In order to denoise, we need to take advantage of some additional information
or structure in the data. It is well known that genes act in complex pathways which
produces an underlying correlation structure in the data matrix Y. Thus, we want to
borrow information using all genes to help denoise the entire matrix.
To do this, we adopt an empirical Bayes approach, where the prior parameters αgc and βgc
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are estimated from the data for each gene g and cell c. Let us reparameterize the Gamma
distribution in terms of its mean µgc and its variance vgc. The first step of the procedure
is to estimate µgc. This step produces the informative prior means which help to denoise.
Consider a gene of interest g. To model its relationship with other genes, we use a Poisson
generalized linear model with a log link function. The log normalized counts of all other













Since the number of genes often far exceeds the number of cells, a penalized Poisson Lasso
regression is used to shrink most of the regression coefficients to zero. We performed the
Poisson Lasso regression using the glmnet R package (Friedman, Hastie, and Tibshirani
2010). In a Lasso regression, a penalty parameter lambda is added to the likelihood to




















where l(y, η) is the Poisson negative log-likelihood
A large penalty would correspond to a model with very few nonzero coefficients while a
small penalty would correspond to a model with many nonzero coefficients. The genes that
have nonzero coefficients can be thought of as genes that are good predictors of the gene
being estimated. We believe that this accurately reflects true biology since genes often only
interact with a limited set of genes. To prevent overfitting, we select the penalty parameter
with the lowest k-fold cross-validation error and use the associated model to predict the
regression predictions µ̂gc. We illustrate in Section 2.5.1 how cross-validation improves
performance. We fit the Poisson Lasso regression for each gene and use the estimated µ̂
as the matrix of prior means. The process of predicting each variable in a matrix using all
other variables as predictors is called nodewise regression. The nodewise Lasso regression
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has been used to estimate sparse inverse covariance matrices (Meinshausen and Buhlmann
2006).
The next step is to estimate the prior variance by assuming a noise model across cells which
is parameterized for each gene by a dispersion parameter φg for a gene g. We consider three
models for φg:
1. Constant coefficient of variation φcvg
2. Constant Fano factor φFg
3. Constant variance φvg
A constant coefficient of variation corresponds to a constant shape parameter αgc = αg
in the gamma prior and a constant Fano factor corresponds to a constant rate parameter
βgc = βg. See Appendix 1 for a derivation. To determine which model for φg is the most
appropriate, we calculate the marginal likelihood across cells under each model and select
the one with the highest maximum likelihood. We then set φ̂g to the maximum likelihood
estimate. Given φ̂g and the choice of noise model, we can derive vgc. We repeat this
procedure for each gene.
Now that we have both µ̂gc and v̂gc, we can reparameterize, based on the chosen model for
φ̂g, into the usual shape and rate parameters of the Gamma distribution, α̂gc and β̂gc. With
the prior parameters estimated, we can then derive the posterior distribution as
λgc|Ygc, α̂gc, β̂gc ∼ Gamma(Ygc + α̂gc, sc + β̂gc) (2.4)
The SAVER estimate λ̂gc is the posterior mean, which can be written as a weighted com-














Figure 1: For a given value of the prediction µgc, the SAVER estimate (blue triangle) is
a weighted average between the observed Ygc/sc (black point) and the prediction µgc (red
line).
The fact that the posterior mean is a weighted average of the regression prediction and the
normalized observed expression is not a surprise. Typical of empirical Bayes methods, the
observed data is shrunken towards the mean. However, instead of shrinking towards the
global mean, the observed count is shrunken towards its specific informative prior mean.
The weights themselves are a function of the size factor sc and β̂gc. β̂gc contains information
about the gene’s predictability φ̂g and its prediction µ̂gc. The SAVER estimate for genes for
which the prediction is poor (large φg) or that are already highly counted (large Ygc) will be
shrunken more towards the observed Ygc/sc. On the other hand, the SAVER estimate for
genes for which the prediction is more trustworthy (small φg) or for which the raw count is
low (small Ygc) will be shrunken more towards the prediction µ̂gc. Figure 1 shows example
scenarios.
The entire SAVER procedure is summarized in Figure 2.
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Figure 2: Overview of SAVER procedure for gene g.
2.3.3. Examples of Downstream Analyses with SAVER Posteriors
One advantage of SAVER over other denoising methods is that it gives a posterior dis-
tribution which serves to quantify estimation uncertainty. For downstream analyses such
as clustering or visualization, ignoring the uncertainty and directly using the SAVER es-
timates would yield cleaner results. However, incorporating the variation in the posterior
distribution is critical for analyses which require quantification of noise such as statistical
testing. Post-denoising inference will not be discussed in this work, but it is an area of
research worth investigating further. Here, we will give two examples of how the SAVER
posterior can be used in downstream analyses.
Gene Pair Correlations
First, suppose we want to find the correlation between two genes g and g′ across cells, namely
Cor(λg,λg′), where λg = (λg1, . . . , λgC). As the SAVER posterior mean λ̂gc is a point
estimate, calculating the correlation between the SAVER estimates will be an overestimate
of the magnitude of the correlation since the variance is not taken into account:
∣∣∣Cor(λ̂g, λ̂g′)∣∣∣ ≥ |Cor(λg,λg′)|
Thus, if we want to calculate the correlation between gene g and g′, we need to adjust
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Cor(λ̂g, λ̂g′) by gene-specific correlation factors γg and γg′ such that
Cor(λg,λg′) = γgγg′Cor(λ̂g, λ̂g′)
Derivation of γg can be found in Appendix 2. Briefly, we use the law of total variance and





We see that the posterior uncertainty is captured by the term E[Var(λg|Z)]. The sample-
adjusted correlation is simply a function of the sample correlation, sample variances and
the average of the posterior variances.
Differential Expression
One of the most commonly performed analysis in RNA-seq is discovering genes which are
differentially expressed in two or more subgroups. To take into account the SAVER pos-
terior uncertainty, we take a missing data imputation approach where we perform random
sampling from the posterior distribution N times via
λ(1)gc , . . . , λ
(N)
gc |Ygc, α̂gc, β̂gc ∼ Gamma(Ygc + α̂gc, sc + β̂gc)
This gives us N sampled datasets λ(i). We then perform testing via the Wilcoxon rank
sum test on each dataset and acquire a vector of test statistics T(i) = {T (i)1 , . . . , T
(i)
G } where
G is the total number of genes tested. Finally, T(i) is combined for sampled i = 1, . . . , N
using Rubin’s rules for multiple imputation (Rubin 1987) and p-values for each gene are
derived. An alternative to performing sampling would be to perform distributional tests on
the posterior distributions themselves. This would be an interesting future research topic.
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2.4. Evaluation and Results
2.4.1. RNA FISH Experiment
One of the main difficulties in assessing the performance of denoising methods is that
there is no way to quantify the true RNA molecule count λgc for every gene g. The best
existing technology is called single-molecule RNA fluorescence in situ hybridazation (RNA
FISH) (Femino et al. 1998; Raj et al. 2008). RNA FISH is an imaging technique where
fluorescent probes are engineered to bind to certain RNA molecules of interest inside the cell.
Microscopic analysis is then performed to count the number of fluorescent RNA molecules
in each cell. This is considered the gold standard in terms of RNA quantification. One
drawback with the method is that it is unable to capture all of the genes simultaneously
in one cell. Only about 10-30 genes can be captured simultaneously using single-molecule
RNA FISH, although a recent technology called MERFISH (Chen et al. 2015; Xia et al.
2019) allows capture of upwards of 10,000 genes but with lower accuracy.
Torre et al. (2018) used single-molecule RNA FISH to profile the expression of 26 drug resis-
tance markers and housekeeping genes in 7,000 to 88,000 cells. In addition, an scRNA-seq
technology called Drop-Seq (Macosko et al. 2015) was used to sequence the transcriptomes
of 8,640 cells from the same cell line. After filtering, the observed count matrix consisted
of 12,241 genes and 8,498 cells with 15 genes overlapping with the FISH dataset. As these
cells come from a homogeneous population, we would expect that the expression profiles
measured from RNA FISH and Drop-seq would be similar at the distribution level. Thus,
this dataset served as an ideal evaluation of SAVER’s performance in recovering the true
gene expression characteristics.
Since FISH and scRNA-seq were performed on different cells, the FISH and scRNA-seq de-
rived estimates can only be compared in distribution. Accurate recovery of gene expression
distribution is important for identifying rare cell types, identifying highly variable genes,
and studying transcriptional bursting. We applied SAVER, MAGIC, and scImpute to the
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Figure 3: Comparison of a) Gini coefficient and b) Kolmogorov-Smirnov statistic for 15
genes between FISH and one of Drop-seq, SAVER, MAGIC, and scImpute.
Drop-seq data and calculated the Gini coefficient, a measure of gene expression variability,
for the FISH, Drop-seq, and denoising methods for these 15 overlapping genes (Fig. 3a).
For SAVER, we sampled from the SAVER posterior rather than using the SAVER estimates
directly since it is important to incorporate the estimation uncertainty. The Gini coefficient
has been shown to be a useful measure for identifying rare cell types and sporadically ex-
pressed genes in the original FISH-based study of this cell line (Shaffer et al. 2017). Thus,
accurate recovery of the Gini coefficient would allow the same analysis to be performed with
scRNA-seq across all genes.
For all genes, SAVER effectively recovers the FISH Gini coefficient, which Drop-seq grossly
overestimates. MAGIC underestimates the FISH Gini coefficients, possibly because MAGIC
tends to remove not only technical noise but also true biological variation. scImpute per-
forms better than MAGIC at recovering the Gini coefficient but not as well as SAVER.
Next, we compared the distribution of the FISH expression and the Drop-seq, SAVER,
MAGIC, and scImpute recovered expression for each gene by calculating the Kolmogorov-
Smirnov statistic between the distributions. The larger the Kolmogorov-Smirnov statistic,
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Figure 4: Kernel density estimates of cross-cell expression distribution of LMNA and
CCNA2.
the more dissimilar the distributions. Figure 3b reveals that the SAVER recovered dis-
tributions are closer to their FISH counterparts than the original Drop-seq, MAGIC, and
scImpute expression distributions. In addition, we plotted the kernel smoothed gene ex-
pression densities for two genes, LMNA and CCNA2 (Fig. 4). The distributions of the
SAVER expression overlaps almost completely with the RNA FISH distributions. Drop-seq
produces a large peak at zero due to the efficiency loss. MAGIC oversmooths the gene
expression and produces a large peak at the mean gene expression while scImpute appears
to produce a multi-modal distribution.
Next, we took a look at gene-gene correlations. More accurate assessment of gene-gene
correlations allows for better characterization of gene regulatory pathways and networks.
The FISH data contains cells which have simultaneous measurements for multiple genes
so we can assess how pairs of genes are correlated. For each gene-gene correlation in the
FISH data, we assessed the same gene pair correlation for Drop-seq, SAVER, MAGIC,
and scImpute (Fig. 5). For the SAVER gene-wise correlations, we used the correlation
adjustment method calculated in Section 2.3.3. When we compare the Drop-seq correlation
with those of FISH, we see that the correlations computed from the Drop-seq counts are
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Figure 5: Comparisons of gene pair correlations computed from Drop-seq original counts,
SAVER, MAGIC, and scImpute with those computed from FISH counts.
dampended compared to their FISH counterparts. Correlations computed by SAVER are
much closer to their corresponding FISH values. On the other hand, MAGIC inflates all the
gene-pair correlations, suggesting that it induces spurious correlation. scImpute averages
the correlations, leading to biased estimates of the true correlation.
This behavior can be further visualized through the scatterplot of two genes, BABAM1
and LMNA (Fig. 6). The FISH correlation between BABAM1 and LMNA is 0.67 and
the scatterplot reveals a clear positive correlation. The observed Drop-seq contains an
abundance of values close to 0, which deflates the calculated correlation to 0.19. The Pearson
correlation of the SAVER output, calculated using the method in Section 2.3.3, is 0.69. The
gene pair correlation computed using the MAGIC values is 0.97, grossly overestimating the
relationship. The correlation calculated using the scImpute values is 0.34, due to both
discreteness in the data and zeros.
A main danger in gene expression recovery is creating false correlations between genes. This
could happen if the model overfits to the data, or if the final estimates rely too heavily on
the prediction model and neglects the natural gene expression stochasticity between cells.
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Figure 6: Scatterplots of expression levels between BABAM1 and LMNA. Pearson corre-
lations were calculated across 17,095 cells for FISH and 8,498 cells for Drop-seq, SAVER,
MAGIC, and scImpute. The SAVER estimates are represented by the black dots and the
SAVER posterior uncertainty by the blue density.
Figure 7: Gene-to-gene correlations of n = 1,000 genes from a null dataset with no real gene
relationships.
We investigated whether SAVER, MAGIC, and scImpute overfits by creating a null dataset
where there are no real relationships between genes and cells. We permuted the cell labels
for each gene in the melanoma Drop-seq data independently, thereby creating a null dataset
with no real gene-gene correlations. This maintains the marginal distributions of the original
scRNA-seq dataset while destroying all relationships between genes. Between any pair of
genes in the permuted data, the correlation should be very close to zero.
We applied SAVER, MAGIC, and scImpute to this permuted data and calculated gene-
gene correlations for 1,000 randomly selected genes (Fig. 7). Indeed, the correlations
are mostly zero for the observed Drop-seq data. MAGIC grossly inflates the correlations.
Thus, MAGIC is extremely susceptible to introducing spurious correlations in its results.
The correlations are also slightly inflated in the scImpute results. Reassuringly, SAVER
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Figure 8: Highly expressed genes and cells are selected from a real scRNA-seq dataset to
create a reference dataset to serve as the ground truth. Down-sampling simulates efficiency
loss leads to an observed dataset. Expression recovery algorithms are applied to the observed
dataset and performance is measured by calculating the gene-wise and cell-wise correlations
with the reference dataset.
does not inflate the correlations and even shrink them further towards zero; this is expected
since SAVER reduces the noise as compared to the observed counts, and thus should more
reliably estimate the true correlation of zero.
By comparing gene expression distributions and gene pair correlations between the gold
standard RNA FISH data and the scRNA-seq Drop-seq data, we discovered that the abun-
dance of zeros and discreteness of the scRNA-seq Drop-seq data does not reflect the under-
lying biology. SAVER is able to accurately recover the distributional characteristics as well
as gene pair correlations found in RNA FISH while not introducing false correlations.
2.4.2. Down-sampling Experiment
In the previous analysis, we could not evaluate the performance of SAVER in recovering the
true expression since RNA FISH and scRNA-seq were not performed on the same cell. In
this section, we evaluated whether SAVER can accurately recover the true expression level
within each individual cell for each gene by performing down-sampling experiments on four
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scRNA-seq datasets to generate realistic benchmarking datasets. To generate a reference
dataset from real scRNA-seq data, we selected high quality cells and highly expressed genes
from the original dataset to treat as the true expression λgc. These cells and genes would
be the least susceptible to efficiency loss. We generated down-sampled observed datasets by
drawing from a Poisson distribution with mean parameter τc λgc, where τc is the cell-specific
efficiency loss. A schematic of the down-sampling experiment is shown in Figure 8. The
datasets are described below:
1. Baron et al. (2016): Human pancreatic islet data. To generate the reference dataset,
we selected genes that had non-zero expression in 25% of the cells and cells with a
library size of greater than 5,000. We ended up with 2,284 genes and 1,076 cells.
2. Chen et al. (2017): Mouse hypothalamus. To generate the reference dataset, we
selected genes that had non-zero expression in 20% of the cells and cells with a library
size of greater than 2,000. We ended up with 2,159 genes and 7,712 cells.
3. La Manno et al. (2016): Human ventral midbrain data. To generate the reference
dataset, we selected genes that had non-zero expression in 30% of the cells and cells
with a library size of greater than 5,000. We ended up with 2,059 genes and 947 cells.
4. Zeisel et al. (2015): Mouse cortex and hippocampus data. To generate the reference
dataset, we selected genes that had non-zero expression in 40% of the cells and cells
with a library size of greater than 10,000 UMIs. We ended up with 3,529 genes and
1,800 cells. We also filtered out one cell that had abnormally low library size after
gene selection to end up with 1,799 cells.
To mimic variation in efficiency across cells, we sampled τc as follows:
1. 10% efficiency: τc ∼ Gamma(10, 100)
2. 5% efficiency: τc ∼ Gamma(10, 200)
The Baron, Chen, and La Manno datasets were sampled at 10% efficiency and the Zeisel
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dataset was sampled at 5% efficiency. The efficiencies were chosen to match the character-
istics of the down-sampled data with the original full dataset.
Correlations with the reference
We evaluated the performance of the down-sampled counts Ygc, SAVER, MAGIC, and
scImpute in recovering the reference expression λgc. First we calculated the Pearson gene-
wise correlation ρag across cells and the cell-wise correlation ρ
a
c across genes between the
reference and denoising method a. To visualize the correlations, we plotted the density
curves of the gene-wise and cell-wise correlation with the reference for each method (Fig.
9).
First, we will focus on the gene-wise correlations. We see that the observed down-sampled
dataset has relatively poor correlation with the reference data, with most genes having
only a correlation of 0.25-0.50. This shows that the raw scRNA-seq counts are often a
poor representation of the true quantity of RNA molecules, as confirmed by the RNA FISH
experiment. SAVER is able to to improve the gene-wise correlations for a subset of genes
in the datasets while maintaining the original observed correlation for the rest. This is
a result of the cross-validation step in the Lasso regression, which prevents overfitting the
data. For the Chen and Zeisel datasets, there are more genes which are improved by SAVER
than for the Baron and La Manno datasets (Fig. 9b). MAGIC and scImpute on the other
hand actually perform worse than the observed down-sampled data at reconstructing the
reference.
Similar patterns exist in the the cell-wise correlations with the reference. SAVER is able to
improve the cell-wise correlations for all cells over the observed down-sampled data while
MAGIC and scImpute produce mixed results. The cell-wise correlations are generally higher
than the gene-wise correlations because the dynamic range of expression across genes for
one cell is much greater than the dynamic range of expression across cells for one gene. As
a result, down-sampling leads to lower gene-wise correlations.
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Figure 9: Density plots of (a) gene-wise and cell-wise correlations with the reference and (b)
% change in correlation compared to the observed data for SAVER, MAGIC, and scImpute.
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Figure 10: Comparison of gene-to-gene (left) and cell-to-cell (right) correlation matrices
of recovered values with the true correlation matrices, as measured by correlation matrix
distance (CMD).
Correlation Matrix Distance
Next, we wanted to assess the effect of down-sampling and denoising on the correlation
structure of the reference datasets. We discovered in the RNA FISH study that the noise
from scRNA-seq experiments reduces the strength of pair-wise correlations between genes.
In addition, accurate assessment of pair-wise cell correlations is critical for clustering and
visualization of cells, which depend on the calculated similarity measure between cells. We
evaluated how well each method recovers the reference correlation matrices using the corre-
lation matrix distance (CMD) (Herdin et al. 2005). The CMD is a measure of the distance
between two correlation matrices with range from 0 (equal) to 1 (maximum difference). The




We calculated the CMD between the reference correlation matrices and observed, SAVER,
MAGIC, and scImpute correlation matrices (Fig. 10). SAVER lowers the CMD for both
gene-to-gene correlation matrices and cell-to-cell correlation matrices. MAGIC and scIm-
pute perform similarly to the observed down-sampled count matrix.
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Figure 11: Comparison of gene-to-gene (left) and cell-to-cell (right) correlation matrices
of recovered values with the true correlation matrices, as measured by correlation matrix
distance (CMD).
Differential Expression Analysis
To investigate the effect of SAVER on downstream analyses, we performed differential
expression on the down-sampled data. In the Zeisel study, two subclasses of cells — 351
CAPyr1 and 389 CA1Pyr2 cells — were identified by the original authors. We performed
differential expression analysis of these two subclasses using the SAVER outputs as outlined
in Subsection 2.3.3. We compared the performance of SAVER with scRNA-seq differential
expression methods MAST (Finak et al. 2015), scDD (Korthauer et al. 2016), and SCDE
(Kharchenko, Silberstein, and Scadden 2014). MAST employs a hurdle model, modeling
both the proportion of genes expressed and the continuous non-zero expression. scDD
models the expression counts as coming from a Dirichlet process mixture and tests for
differences in distribution via the Bayes factor. SCDE employs a Bayesian model and
tests for differences between a zero-inflation Poisson component and a non-zero negative
biniomial component. FDR control was set to 0.01 and no fold change cutoff was used.
We also estimated the false discovery rate by performing a permutation of the cell labels
and determining the number of genes called as differentially expressed according to the
p-value threshold defined for the unpermuted data. This number divided by the number
of differentially expressed genes in the unpermutated data is the estimated false discovery
rate for that one permutation. The final estimated false discovery rate is the average of the
estimated false discovery rates over 20 permutations.
Figure 11 shows the results after performing differential expression. For the reference
26
dataset, all methods detect around 2,500-3,000 genes. After down-sampling, the number of
differentially expressed genes detected is much lower. SAVER is able to detect 1,744 genes
in the down-sampled dataset whereas the other methods all detect less than 1,000. SAVER
is also able to maintain accurate FDR control. Thus, SAVER has greater power to detect
differentially expressed genes than just using the observed data.
Cell Clustering
Next, we performed cell clustering on the reference, observed, and recovered datasets using
a popular single-cell analysis package called Seurat (Butler et al. 2018; Stuart et al. 2019).
Cell clustering is a common downstream analysis to identify and characterize different cell
types. A typical Seurat workflow consists of first projecting the high-dimensional gene
expression matrix into a low-dimensional representation using PCA. A K-nearest neighbors
graph is built using the top principal components and modularity optimization techniques
such as the Louvain method for community detection (Blondel et al. 2008) is used to identify
the clusters.
We performed clustering on the reference dataset using Seurat and the reference-derived cell
type clusters were treated as the truth. Clustering accuracy on the observed and recovered
datasets was assessed by the Jaccard index and by t-SNE visualization (Van Der Maaten
and Hinton 2008). Figure 12 shows the t-SNE plots for the Baron, Chen, La Manno, and
Zeisel datasets for the reference, observed down-sampled, recovered datasets. k denotes the
number of clusters found in the observed dataset, which was used as an input to scImpute.
SAVER achieves a higher Jaccard index than the observed for all datasets, while MAGIC
and scImpute have a consistently lower Jaccard index. Even though the Jaccard index for
SAVER in the Chen and La Manno datasets are only slightly higher than the observed, the
t-SNE plots reveal that SAVER clustering of the cells is a more accurate representation of
the reference data than the observed. Due to rampant oversmoothing, MAGIC recovered
datasets have strange t-SNE visualizations and cells are not well separated. scImpute, which
requires as input the number of clusters expected in the data, forms cell clusters which are
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Figure 12: Cell clustering and t-SNE visualization of the Baron, Chen, La Manno, and
Zeisel reference, observed, and recovered down-sampled datasets. The colors represent
the cell types identified by Seurat in the reference dataset. The Jaccard index measuring
similarity between the observed/recovered clustering and reference clustering is displayed
in the bottom right.
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Figure 13: t-SNE visualization of 7,387 mouse cortex cells for the observed data (left) and
SAVER (right) colored by cell types determined by Hrvatin et al. (2018).
not found in the reference dataset.
2.4.3. SAVER applied to Subsampled scRNA-seq data
Finally, we applied SAVER to a mouse visual cortex dataset from Hrvatin et al. (2018).
47,209 cells were classified into main cell types and subtypes using marker genes and prior
biological knowledge. We applied SAVER to a random subset of 7,387 cells and performed t-
SNE visualization of the observed versus the SAVER-recovered cells (Fig. 13). A population
of excitatory neurons is highlighted, and the individual subtypes are colored according
to labels given by Hrvatin et al. (2018). In the t-SNE plot of the subsampled original
counts, the subtypes are not well separated and are mostly indistinguishable. SAVER
distinguished the individual subtypes with clear separation. Thus, SAVER is able to recover
the subtypes of cells using only a subsample of the data. This example is common in our
general experience with SAVER: It does not affect well-separated cell types but identifies
cell types and states for which the evidence in the original data may be weak.
2.4.4. Additional Properties
The performance of SAVER can vary depending on the sequencing depth, the number of
cells, the amount of heterogeneity in the population, and gene-specific properties. We will
address these factors one by one.
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Figure 14: Histograms of cell-specific efficiencies at each mean efficiency level for n = 1, 799
cells.
Ref 25% 10% 5%
Mean exp 4.20 1.04 0.42 0.21
% zero 27.3% 61.9% 77.6% 86.1%
Table 1: Mean expression and percentage zero at each efficiency.
Sequencing depth
To examine the performance of SAVER under various sequencing depths, we down-sampled
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Figure 2 Evaluation of SAVER by down-sampled mouse brain dataset. (a) Schematic of down-sampling experiment. (b) 
Performance of algorithms measured by correlation with reference, on the gene level (left) and on the cell level (right). 
Percentage improvement over using the observed data is shown in the lower two panels. SAVER is more closely correlated 
with the truth across both genes and cells. (c) Comparison of gene-to-gene (left) and cell-to-cell (right) correlation matrices 
of recovered values with the true correlation matrices, as measured by correlation matrix distance (CMD). (d) Differential 
expression (DE) analysis between CA1Pyr1 cells (n = 351) and CA1Py2 cells (n = 389). SAVER yields more significant 
genes across efficiencies (left), while still controlling false discovery rate at 0.01 (right). (e) Cell clustering and t-SNE 
visualization of seven cell types. Classification accuracy of the 5% down-sampled observed dataset and recovery methods as 
compared to the reference classification is shown.
Efficiency Ref 25% 10% 5%
% zero 27.3 61.9 77.6 86.1














































































































































Figure 15: Performance of algorithms measured by correlation with reference, on the gene
level (left) for n = 3, 599 genes and on the cell level (right) for n = 1, 799 cells. Percentage
improvement over using the observed data is shown in the lower two panels. Box plots show
the median (center line), interquartile range (hinges), and 1.5 times the interquartile range
(whiskers); outlier data beyond this range are not shown.
We then compared gene-wise correlations and cell-wise correlations with the reference for
observed, SAVER, MAGIC, and scImpute (Fig. 15). Gene-wise and cell-wise correlations
with the reference decreases as efficiency decreases, yet SAVER maintains the highest cor-
relation with the reference across all efficiencies. The biggest improvement for SAVER over
the observed occurs at the lowest efficiency of 5%.
Next, we calculated the correlation matrix distance (CMD) between the reference and
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Percentage improvement over using the observed data is shown in the lower two panels. SAVER is more closely correlated 
with the truth across both genes and cells. (c) Comparison of gene-to-gene (left) and cell-to-cell (right) correlation matrices 
of recovered values with the true correlation matrices, as measured by correlation matrix distance (CMD). (d) Differential 
expression (DE) analysis between CA1Pyr1 cells (n = 351) and CA1Py2 cells (n = 389). SAVER yields more significant 
genes across efficiencies (left), while still controlling false discovery rate at 0.01 (right). (e) Cell clustering and t-SNE 
visualization of seven cell types. Classification accuracy of the 5% down-sampled observed dataset and recovery methods as 
compared to the reference classification is shown.
Efficiency Ref 25% 10% 5%
% zero 27.3 61.9 77.6 86.1














































































































































Figure 16: Comparison of gene-to-gene (left) and cell-to-cell (right) correlation matrices
of recovered values with the true correlation matrices, as measured by correlation matrix
distance (CMD).
both gene-to-gene and cell-to-cell correlation matrices increases as efficiency decreases, yet
SAVER maintains the lowest CMD with the reference across all efficiencies. Similarly, the
improvement of SAVER is most noticeable at the lowest efficiency of 5%.
To investigate the impact of sequencing depth on downstream analysis, we repeated the
Zeisel differential expression analysis and cell clustering and visualization for each efficiency.
In the differential expression analysis, the number of detected differentially expressed genes
decreases as efficiency decreases, while SAVER maintains the highest number of differen-
tially expressed genes across all efficiencies (Fig. 17).
In the cell clustering analysis, the Jaccard index decreases and the clusters become less
defined in the t-SNE visualization as efficiency decreases (Fig. 18). SAVER maintains high
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Figure 2 Evaluation of SAVER by down-sampled mouse brain dataset. (a) Schematic of down-sampling experiment. (b) 
Performance of algorithms measured by correlation with reference, on the gene level (left) and on the cell level (right). 
Percentage improvement over using the observed data is shown in the lower two panels. SAVER is more closely correlated 
with the truth across both genes and cells. (c) Comparison of gene-to-gene (left) and cell-to-cell (right) correlation matrices 
of recovered values with the true correlation matrices, as measured by correlation matrix distance (CMD). (d) Differential 
expression (DE) analysis between CA1Pyr1 cells (n = 351) and CA1Py2 cells (n = 389). SAVER yields more significant 
genes across efficiencies (left), while still controlling false discovery rate at 0.01 (right). (e) Cell clustering and t-SNE 
visualization of seven cell types. Classification accuracy of the 5% down-sampled observed dataset and recovery methods as 
compared to the reference classification is shown.
Efficiency Ref 25% 10% 5%
% zero 27.3 61.9 77.6 86.1














































































































































Figure 17: Differential expression (DE) analysis between CA1Pyr1 cells (n = 351) and
CA1Py2 cells (n = 389). SAVER yields more significant genes across efficiencies (left),
while still controlling false discovery rate at 0.01 (right).
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Figure 18: Cell clustering and t-SNE visualization of the Zeisel dataset across efficiencies
for n = 1, 799 cells.
By performing the down-sampling experiment at three different efficiencies for the Zeisel
data, we discovered that as sequencing depth decreases, the observed data becomes less
representative of the true expression data. However, SAVER is able to recover the original
data, especially so for low efficiency setting.
Number of cells
Next, we wanted to see the effect of the number of cells on SAVER performance. Often,
the number of cells and sequencing depth go hand-in-hand when choosing to design an
experiment. An experiment with a large number of cells will usually have low sequencing
depth and vice versa. The Zeisel down-sampled dataset contains 1,799 cells. We calculated
the gene-wise and cell-wise correlations at subsamples of 250, 500, 1,000, and 1,500 cells
across the three efficiencies (Fig. 19).
As the number of cells increases, the gene-wise correlations increase as well across all effi-
ciencies (Fig. 19a). At lower efficiencies, increasing the number of cells has a larger effect on
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Supplementary Figure 10 Effect of subsampling cells on SAVER correlation with the Zeisel reference dataset at 25%, 
10%, and 5% efficiencies. Cells were randomly subsampled at each specified sample size. Density plots showing 
genewise (a) and cell-wise (b) correlations with reference across efficiencies reveal that SAVER performs at least as 
well as the observed even at small sample sizes. (c) Median percentage improvement over observed in terms of gene-
wise correlations. As sample size increases, SAVER outperforms the observed to a greater extent. (d) Median percentage 
improvement over observed in terms of cell-wise correlations. Improvements in cell-wise correlations do not depend on 
sample size.
Figure 19: Effect of subsampling cells on SAVER correlation with the Zeisel reference
dataset at 25%, 10%, and 5% efficiencies. Cells were randomly subsampled at each specified
sample size. Density plots showing genewise (a) and cell-wise (b) correlations with reference
across efficiencies rev al that SAVER performs at l ast as well as the observed even at
small sample sizes. (c) Median percentage improvement over observed in terms of gene-

















Figure 20: Comparison of the performance of SAVER on a homogeneous cell population
versus a heterogeneous cell population.
to note that when the number of cells is small, SAVER does not try to over-aggressively use
information that is not there. As a result, the performance of SAVER will always improve
on the observed data. Interestingly, the cell-wise correlation improvement depends on the
efficiency but not on the number of cells (Fig. 19b,d). This is likely because cells behave
independently so adding additional cells does not improve cell-wise correlations.
Cell Heterogeneity
Another factor that affects the performance of SAVER is the heterogeneity of the cell pop-
ulation in the study. To investigate this, we analyzed the down-sampled 5% Zeisel data,
which contained 834 Pyramidal CA1 cells as identified by the authors. We selected these
834 cells and treated this as the homogeneous population. Then, we took a random sample
of 834 other cells, which are a mix of different cell types, and treated this as the heteroge-
neous population. We applied SAVER to these two datasets separately and evaluated the
performance by calculating the gene-wise and cell-wise correlations with the reference data.
The observed homogeneous dataset had lower gene-wise and cell-wise correlations with the
reference than the observed heterogeneous dataset (Fig. 20). SAVER improves on the
gene-wise correlation for both the homogeneous and heterogeneous datasets with greater
improvement in the heterogeneous population. SAVER also substantially improves the
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Figure 21: Comparison of gene-wise correlation percentage improvement over observed for
5% Zeisel SAVER recovered expression across gene metrics such as mean expression, %
nonzero, and Fano factor for n = 3, 599 cells. The red line represents the moving average.
cell-wise correlations with the reference, with greater improvement in the homogeneous
population which in the observed data, had much lower correlation than the heterogeneous
population.
Regardless of the composition of cell types in the data, SAVER improves on both gene-wise
and cell-wise correlations. The biggest gains in gene-wise correlation are in heterogeneous
datasets where there is more information to leverage gene relationships. The biggest gains in
cell-wise correlation are in homogeneous datasets where the observed cell-wise correlations
are low compared to heterogeneous datasets.
Gene properties
Properties of specific genes such as mean expression level, percentage of cells with non-
zero expression, and variability of the expression across cells can affect the performance of
SAVER in recovering the gene. To study these effects, we analyzed the 5% down-sampled
Zeisel dataset and compared the percent improvement in gene-wise correlation with the
reference over observed with mean expression, percent non-zero cells, and variability of
expression (Fig. 21).
For genes with high expression, expression in a high percentage of cells, or high dispersion,




Supplementary Figure 16 Density plots of the SAVER estimates for true zeros in the reference Zeisel dataset and down-
sampled zeros which were non-zero in the reference dataset looking at (a) all genes and (b) the top 200 predictable genes as 
defined by the size of the correlation adjustment factor derived in Supplementary Note 2. SAVER estimates for true zeros are 
seen to be smaller than the down-sampled zeros. 
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Figure 22: Density plots of the SAVER estimates for true zeros in the reference Zeisel
dataset a d down-s mpled zeros which were non-zero in the reference dataset looking at
(a) all genes and (b) the top 200 predictable genes as defined by the size of the correlation
adjustment factor 2.6.
expression of these highly expressed, variable genes are less subject to noise so the observed
values are good estimates for the true expression. SAVER recognizes this and puts more
weight on the observed values. For genes with very low expression, expression in few cells, or
low dispersion, SAVER also does not perform much better than the observed because of the
lack of information available to generate reasonable predictions. Once again, SAVER can
identify these genes and adaptively does not try to overfit. With the exception of these very
highly expressed or lowly expressed genes, SAVER substantially improves on the gene-wise
correlations with the reference.
Identification of true zeros
A difficult question to address in scRNA-seq expression analysis is whether an observed
zero is a true zero, i.e. the true expression of the gene is zero, or an induced zero due to
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low sampling efficiency. Here, we wanted to see if SAVER could distinguish between true
zeros and sampled zeros. Using the Zeisel reference dataset, we classified observed zero
expression in the 25%, 10%, and 5% down-sampled datasets as either true zeros or sampled
zeros. Then we compared the SAVER estimates for these two groups (Fig. 22).
The SAVER estimates are slightly higher for the sampled zeros than the true zeros for all
genes, but when restricted to the top 200 predictable genes, SAVER is able to more clearly
distinguish the sampled zeros from the true zeros.
2.4.5. Third Party Evaluations
The plethora of scRNA-seq denoising methods being published has prompted many re-
searchers to perform third party evaluations of denoising or imputation. One of the first
such studies was conducted by Andrews and Hemberg (2019). They focused on evalu-
ating the risk of producing false positive or irreproducible differential expression results
when using SAVER (Huang et al. 2018), MAGIC (Dijk et al. 2018), scImpute (Li and Li
2018), DrImpute (Gong et al. 2018), knn-smooth (Wagner, Yan, and Yanai 2018), and DCA
(Eraslan et al. 2019). Through a simulation study, all methods were found to increase the
sensitivity to detect gene-gene correlations between lowly expressed differentially expressed
genes, although SAVER was the only method to not generate false positive correlations
between independently drawn genes. In a real data permutation study, Andrews and Hem-
berg (2019) discovered that MAGIC, DCA, and knn-smooth consistently produced a large
number of false positives, while the performance of DrImpute and SAVER were variable
across datasets. In the end, the authors concluded that SAVER was the safest method to
use, although statistical tests should be applied on the original data.
A study by Tian et al. (2019) created pseudo single-cell datasets using admixtures of five
distinct cancer cell lines. They evaluated many combinations of normalization, imputa-
tion, clustering, trajectory, and data integration. In terms of imputation, SAVER, knn-
smooth, and DrImpute were evaluated. They discovered consistently satisfactory results
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when SAVER and DrImpute were used in combination with other methods, although they
noted that SAVER was more sensitive to normalization method. A similar study by Vieth
et al. (2019) used nine simulated differential expression setups to evaluate several scRNA-seq
data pipelines, of which one step was imputation. SAVER, DrImpute, and scone (Cole et al.
2019) were evaluated. The authors found that DrImpute and scone rarely improved perfor-
mance and actually decreased performance in some cases. SAVER on the other hand was
found to never make things worse and maintains proper FDR control. The best performing
pipeline included SAVER as the imputation step.
The most comprehensive evaluation of scRNA-seq imputation and denoising methods to
date was conducted by Hou et al. (2020). 18 different methods were compared and perfor-
mance was evaluated by similarity to bulk RNA-seq samples and ability to recover biologi-
cal signals in downstream analyses like differential expression, unsupervised clustering, and
trajectory analysis. The authors discovered most methods were able to capture biological
expression found in bulk RNA-seq but did not greatly improve downstream analysis. How-
ever, they noted that MAGIC, knn-smooth, and SAVER most consistently outperformed
other methods.
2.5. Topics in Lasso Regression
2.5.1. Cross-validation
The performance of SAVER is reliant on generating quality predictions of gene expression to
serve as the informative prior mean. In SAVER, we estimate the prior mean of the gamma
distribution using a k-fold cross-validated Poisson Lasso regression. We then select the
model with the lowest cross-validated error and use that model to generate the predictions.
To evaluate if choosing the model with the lowest cross-validation error is warranted, we
turned to the down-sampling experiment described in Section 2.4.2 with the Zeisel dataset.
For each gene in the observed down-sampled dataset, we performed the Poisson Lasso
regression for a grid of shrinkage penalty parameters λi, i = 1, . . . , 100. We used the model
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Figure 23: Poisson Lasso regression cross-validation plots from Glmnet and correlation with
Zeisel reference plots for five genes from the 5% efficiency dataset. The x-axis represents the
size of the shrinkage penalty in the LASSO regression from smallest to largest. The dotted
vertical line represents the model with the lowest cross-validation error. The horizontal line
is the observed correlation with the reference and the black points represent the correlation
of the SAVER estimate with the reference at each value of the shrinkage penalty. The red
points in the cross-validation plot represents the mean cross-validation error as measured
by Poisson deviance and the error bars represent ± 1 standard deviation. The numbers at
the top of each plot denote the number of variables in the model at that shrinkage penalty.
SAVER correlation with the reference is approximately maximized when using the model
with the lowest cross-validation error.
at each λi to generate the SAVER prior predictions and derived the SAVER estimates using
those predictions. We then calculated the correlation of the SAVER estimates for that gene
with that gene’s expression in the reference dataset. The higher the correlation, the better.
Results for five genes are shown in Figure 23.
When λ is large, no variables are contained in the linear model so the prediction is just
the mean expression of the gene. This gives an uninformative prior and the correlation
with the reference of the SAVER estimate is nearly identical to that of the observed data.
As λ decreases in magnitude, variables start entering the model and improve the cross-
validation error. Likewise, the correlation with the reference increases. At a certain λi
in the decreasing sequence, the cross-validation error reaches a minimum. At this point,
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when λ is decreased further and more variables enter the model, the cross-validation error
increases as overfitting occurs. The same phenomenon occurs in the correlation with the
reference. The correlation with the reference is maximized within a close range of the λ
which gives the model with the lowest cross-validation error. As λ decreases past this point,
the correlation with the reference decreases. We note that the peak in correlation does not
correspond perfectly with the model with the lowest cross-validation error but is relatively
close. This behavior is consistent across all genes.
This indicates that the choice of the prior means is extremely important for the performance
of SAVER denoising. Cross-validation enables us to identify which genes are predictable
and which genes are not. The genes which are not predictable will naturally have the lowest
cross-validation error be at the model with no variables. Thus, we use an uninformative
prior mean and the SAVER estimate is merely the observed values shrunken towards the
grand mean. However, when there is signal to be gleaned, as evidenced by a lower cross-
validation error, SAVER is able to use the informative prior mean predictions to generate
SAVER estimates with much greater signal. Overfitting appears to decrease performance
of the SAVER estimates.
2.5.2. Computational Considerations and Lasso Approximations
One of the main drawbacks with the SAVER method is the computational costs for large
datasets. The main two steps of SAVER are the prior mean estimation with the nodewise
Lasso regression and the prior variance estimation by maximizing the marginal likelihood
given the prior means. The entire process is highly parallelizable, yet performance issues in
speed still exist.
For the melanoma dataset with 12,241 genes and 8,498 cells, the variance estimation took
about 10 minutes on one core of a standard laptop. However, the bottleneck exists with the
cross-validated Lasso regression. For one gene in the melanoma dataset, one cross-validated
Lasso regression takes about 20 seconds. Calculating the Lasso predictions for all 12,241
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genes takes roughly 68 hours on one computing thread. Thus, about 99% of the total
computation time is occupied by the Lasso prediction procedure. Running SAVER on 20
cores would lead to a total compute time of just over 3 hours, which is more palatable but
would not cut it for larger datasets of 50,000 or more cells.
Thresholding using Maximum Absolute Correlation
As a result, we looked for certain ways to reduce the computation time in the nodewise
Lasso regression. We discovered that some genes were never selected as predictors in the
Lasso regression. These were genes with a mean expression of less than 0.1. By removing
these genes from the prediction matrix, we can cut the number of genes in the prediction
matrix by 2-10 fold, depending on the sparsity of the data.
In addition, we noticed that there would be a large proportion of genes for which the model
with the lowest cross-validation error would be the null model. Thus, we sought to identify
these genes prior to performing the Lasso regression so that we can directly use the mean
gene expression as the uninformative prior instead of having to run the Lasso regression.
One metric we looked at was the maximum absolute correlation between the response and




Here, we assume that xg′ is standardized. In fact, it can be shown that the smallest value








We noticed that for genes with large rmax, the model with the lowest cross-validation error
would often contain many variables. On the other hand, for genes with small rmax, the null
model would be selected. Thus, we decided to filter genes based on a threshold of rmax —
if rmax for a gene is below the threshold, we use the null model and forgo the k-fold cross
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validated Lasso.
To determine the threshold, we needed a measure of predictability. Consider the metric zg
zg =
√
CV (λmax,g)− CV (λcv,g)
se(CV (λcv,g))
,
where CV (λ) denotes the average cross-validation error computed using the model evaluated
at λ, λcv,g is the value of the penalty parameter at the lowest cross-validation error for gene
g, and se(CV (λcv,g)) is the estimated standard error of the CV (λcv,g) across the k folds.
zg functions as a modified z-score of the difference in cross-validation error between the
null model evaluated at λmax,g and the model selected at λcv,g. We then analyzed the
relationship between rmax and z across all genes in the melanoma dataset (Torre et al.
2018), a differentiating stem cell dataset (Klein et al. 2015), and the down-sampled Zeisel
mouse brain dataset (Zeisel et al. 2015) (Fig. 24).
In all three datasets, there is a clear and strong relationship between rmax and z. The R
2
value for the linear regression is around 0.82-0.84. For each dataset, we determined the
value of rmax,0.5 which produced a predicted ẑ = 0.5 as fitted by the linear regression. For
genes with rmax less than rmax,0.5, then the null model is used as the predictions for the
prior mean. The number of genes remaining depends on the dataset. 53.4% of genes were
above the cutoff in the Zeisel brain dataset, 37.6% of genes were above the cutoff in the
melanoma dataset, and 16.1% of genes were above the cutoff in the stem cell dataset. Thus,
we can expect speedups of up to 2-6 fold with the implementation of this threshold. Since
the relationship between rmax and z is dataset-specific, we estimate the regression model
to determine the cutoff based on a subset of 100 genes.
Estimating the Cross-Validated Penalty Parameter
Although the rmax threshold is able to reduce the number of Lasso regressions needed to
be fit, the k-fold cross-validation step is still quite time-consuming. We wanted to see if we
could estimate the penalty parameter λ without performing cross-validation. Consider v,
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Figure 24: Relationship between rmax and z for the melanoma, stem cell, and brain datasets.
a) Plot of all genes. Best linear prediction is shown in red. b) Zoomed in on genes with low
rmax. Percentage of genes remaining after thresholding is displayed in the bottom right.
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Figure 25: Relationship between rmax and v
2 for the melanoma, stem cell, and brain
datasets. Best linear prediction is shown in red and R2 of prediction is in the top left.




v can be thought of as a measure of model complexity. If a complex model is chosen, then
we can assume that the gene is predictable, which corresponds to a large rmax. Likewise,
if a simple model or null model is chosen, then we can assume the gene is unpredictable,
which corresponds to a small rmax. We noticed that for the three datasets, there is a strong
linear relationship between v2 and rmax (Fig. 25).
Let v2 = β̂0 + β̂1rmax be the estimated linear model. Then, for a gene g
∗, the estimated
penalty parameter which gives the model with the lowest cross-validation error is
λ̂cv,g∗ = λmax,g∗ exp
(√
max(β̂0 + β̂1rmax,g∗ , 0)
)
Again, since the estimated β̂0 and β̂1 are dataset-specific, we estimate the parameter using
a subset of 200 genes and then predict λ̂cv for the remaining genes. This reduces the
computational time tremendously as instead of performing k different Lasso fits across a
grid of possibly 100 values of λ, we can directly evaluate the Lasso objective at the estimated
λ̂cv,g∗ .
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Simulations on Multivariate Normal Data
To show that this phenomenon exists outside of scRNA-seq datasets, We assessed the rela-
tionship between v2 and rmax in a simulation study. Let X ∈ IRn×p represent an observed
multivariate normal data matrix, where
Xi. ∼ Np(µ,Σ + σ2I)
In the simulation, we let n = 1000 and p = 1000. µ was sampled from a standard normal.
σ was set to 1. The correlation structure of X is determined by the covariance matrix Σ,
here simulated as
Σ = Q∆Qᵀ,
where Q is sampled from the orthogonal group O(p) and ∆ = Diag(δ1, . . . , δ1000) is the
diagonal matrix of eigenvalues. We consider two scenarios,
∆1 = Diag(100, 10, U3, . . . , U1000)
∆2 = Diag(50, 40, 30, 20, 10, U6, . . . , U1000),
where Ui ∼ Unif(0, 0.1).
We performed k-fold cross-validated nodewise Lasso regression on X under each scenario
and calculate v2 and rmax for each variable. Recall that v is the log ratio of λcv and λmax.
We notice that the linear relationship is confirmed in both scenarios (Fig. 26). The R2 for
scenario 1 is 0.88 and the R2 for scenario 2 is 0.74. These values are slightly lower than the
ones obtained from the scRNA-seq datasets but still indicate a strong relationship.
Final Thoughts
With these approximation techniques in mind, the algorithm for performing the approxi-
mation is as follows
1. Run k-fold cross-validated Lasso for the first 100 genes. Fit z ∼ rmax and estimate
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Figure 26: Relationship between rmax and v
2 for a simulated multivariate normal matrix.
rmax cutoff.
2. Run k-fold cross-validated Lasso for next 100 genes above rmax cutoff. Fit v
2 ∼ rmax
for the 200 total genes and estimate λ̂cv,g for each remaining gene g.
3. Run Lasso evaluated at λ̂cv,g for remaining genes above rmax cutoff.
Table 2 compares the runtime of the Lasso regression before implementing the approxima-
tions and after. We see that we obtain a 15 to 30 fold speedup. Although our results are
mostly empirical, it is interesting to note that the maximum absolute correlation is predic-
tive of the shrinkage parameter which minimizes the generalization error. A more thorough
investigation of this phenomenon could be undertaken in the future.
# genes # cells Time before Time after Speedup
Melanoma 12,241 8,498 297 m 15 m 20x
Stem cell 24,175 933 239 m 8 m 30x
Brain 3,529 1,799 22 m 1.5 m 15x




In this chapter, we presented a method called SAVER for denoising single-cell RNA se-
quencing data. SAVER adopts an empirical Bayes model and estimates informative prior
parameters using the expression of other genes. The posterior output of SAVER enables
quantification of estimation uncertainty and prevents overfitting.
We evaluated the performance of SAVER in several experiments. First, we validated the
ability of SAVER to recover distributional characteristics and gene relationships using
single-molecule RNA FISH. Next, we performed a series of extensive tests using a down-
sampling simulation scheme to mimic the noise structure of real scRNA-seq data. We also
evaluated the robustness of SAVER under various conditions and discovered that SAVER is
able to perform at least as well as the observed count data in downstream analyses without
introducing false signals. This was verified by several third party evaluations. Finally, we
explored approximations to nodewise Lasso regression and discovered a relationship between
the cross-validation error of the Lasso regression and the maximum absolute correlation.
As mentioned previously, one of the drawbacks of the SAVER method is the computational
cost. As more and more scRNA-seq datasets approach a hundred thousand or a million cells,
memory usage of both the Lasso regression and the likelihood fitting step is a big concern.
In addition, additional covariates, such as sequencing batch or patient-level variables, are
not considered in the SAVER denoising. These issues are addressed in the next chapter.
This work not only presents a method for denoising scRNA-seq data, but also provides
a flexible framework to perform any sort of denoising. For example, the prior means do
not have to be generated via nodewise Lasso regression. In fact, follow-up work by Wang
et al. (2019) used the SAVER empirical Bayes framework but implemented an autoencoder
to generate the prior predictions based on transfer learning from external datasets called
SAVER-X. The key innovation of the SAVER framework is allowing for informative prior
parameters which enable denoising while characterizing estimation uncertainty via shrinkage
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and the posterior distribution. The flexibility of this framework lends itself to applications
in a wide variety of matrix denoising settings outside the realm of scRNA-seq.
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CHAPTER 3 : Dimension Reduction and Denoising in the Face of Confounding
Variables
Joint work with Nancy R. Zhang1
3.1. Introduction
The identification of and adjustment for observed confounding variables has been extensively
studied in the context of high-throughput sequencing experiments. An important category
of such confounding variables is batch effects. Leek et al. (2010) define batch effects to
be subgroups of measurements which occur in different settings and result in unwanted
variation in the measured data. For examples, samples sequenced in different rounds can
exhibit strong batch effects. In single-cell RNA sequencing, batch effects have been shown
to introduce large unwanted variation in the data matrix (Hicks et al. 2017; Tung et al.
2017). An extraordinary number of methods have been developed to remove batch effects
(Butler et al. 2018; Haghverdi et al. 2018; Hie, Bryson, and Berger 2019; Korsunsky et al.
2019; Polański et al. 2019; Stuart et al. 2019; Welch et al. 2019). These methods primarily
focus on aligning the low-dimensional representations of cells across batches, with some
methods also adjusting the high-dimensional gene expression for batch.
However, batch effects are not the only variable that can cause unwanted variation in
scRNA-seq experiments. scRNA-seq has been used to study the cellular basis of disease in
human patients (Azizi et al. 2018; Grubman et al. 2019; Patel et al. 2014). In addition,
scRNA-seq is being implemented in population-wide expression quantitative trait locus
(eQTL) studies which link disease-causing variation in DNA to changes in gene expression
(Cuomo et al. 2020; Wijst et al. 2020; Wijst et al. 2018). With that comes an array of
technical and confounding variables that extend beyond mere batch effects and involve
patient-level variables such as age and sex, as well as complex experimental designs. In
1M.H. and N.R.Z. conceived this work. M.H., with feedback from N.R.Z., designed the model and
estimation algorithm, implemented the software, designed the in silico experiments, and performed the data
analysis.
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addition, cell-level covariates such as library size and mitochondrial RNA content, the latter
often used as a proxy for cell quality (Ilicic et al. 2016), can lead to spurious variation in the
expression data. Thus, one can view the batch effect correction problem within the more
general framework of observed covariate adjustment and modeling.
Sophisticated representation and machine learning techniques have been developed to char-
acterize the high-dimensional scRNA-seq data through interpretable low-dimensional forms
(Lopez et al. 2018; Wang et al. 2018a; Welch, Hartemink, and Prins 2016). In addition,
the expression matrix is known to exhibit low signal due to the limited amount of RNA in
each individual cell. This has prompted the development of denoising methods to extract
signal from the noise (Dijk et al. 2018; Eraslan et al. 2019; Huang et al. 2018; Li and Li
2018; Wang et al. 2019). However, these representation learning and denoising methods do
not allow for the adjustment of general observed covariates.
In this work, we present a method called α-CVAE based on the conditional variational
autoencoder (CVAE) (Sohn, Yan, and Lee 2015). α-CVAE optimizes a weighted objective
function which encourages disentanglement of latent and observed factors. We motivate
the use of the weighted objective function by drawing parallels to constrained principal
components analysis (CPCA), a linear method for estimating factor models in the presence
of observed factors. We demonstrate the ability of the α-CVAE to model interactions
between latent and observed factors, a scenario where CPCA fails. Next, we extend the
α-CVAE to single-cell RNA sequencing data with a method called SAVER-CVAE. SAVER-
CVAE performs dimension reduction and denoising while adjusting for observed sample-
level and cell-level covariates, such as batch and library size. Through a data-downsampling
experiment, we show that SAVER-CVAE is able to effectively recovers true expression
profiles while modeling library size as an observed covariate. We then compare SAVER-
CVAE to Seurat (Stuart et al. 2019) and scVI (Lopez et al. 2018) in a batch correction
problem and reveal that SAVER-CVAE is able to correct for batch in both the latent space
and the gene expression matrix while Seurat and scVI fail to correct for batch in the latter.
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Finally, we apply SAVER-CVAE to a clinical experiment with large confounding effects and
show that going beyond simple batch removal is necessary.
3.2. Related Works
3.2.1. Nonlinear Dimension Reduction and Denoising in scRNA-seq
Although linear dimension reduction methods such as factor analysis and PCA have a long
history in statistics, they can be limited in representing high-dimensional scRNA-seq data
which lies on a low-dimensional manifold rather than a linear subspace. As a result, nonlin-
ear dimension reduction methods have become powerful tools in scRNA-seq experiments.
For example, locally linear embedding has been used to model cellular trajectories (Welch,
Hartemink, and Prins 2016) and multi-kernel dimension reduction has been used to visualize
and cluster cells in low-dimensional space (Wang et al. 2018a).
For denoising scRNA-seq, scImpute (Li and Li 2018), SAVER (Huang et al. 2018), and
MAGIC (Dijk et al. 2018) were among the first methods to estimate an expression matrix
from the noisy raw count matrix. More recently, neural networks such as the autoencoder
methods DCA (Eraslan et al. 2019) and SAVER-X (Wang et al. 2019) and the variational
autoencoder method scVI (Lopez et al. 2018) have had great success in characterizing
the nonlinear latent gene expression space as well as in denoising the high-dimensional
expression matrix. However, existing denoising methods do not consider the incorporation
of observed covariates with the exception of scVI, which allows for the alignment of discrete
batches but is unable to incorporate complex experimental designs or continuous covariates.
3.2.2. Batch Correction in scRNA-seq
A multitude of methods have been developed for batch correction in single-cell RNA se-
quencing. Recall that batches in scRNA-seq refer to the processing and sequencing of
subgroups of cells, which produces multiple datasets. The goal of existing batch correction
methods is to align the cells across these datasets so that variation due to batch effects is
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removed. The first methods developed were Seurat CCA (Butler et al. 2018) and mnnCor-
rect (Haghverdi et al. 2018). Seurat CCA projects cells from two batches into a shared low
dimensional space via canonical correlation analysis (CCA) and implements dynamic time
warping to align the datasets. mnnCorrect identifies mutual nearest neighbors in a pair of
datasets and calculates a difference vector which is then used to translate one dataset to the
other serving as a reference. A new version of Seurat called Seurat v3 integration (Stuart
et al. 2019) borrows the mutual nearest neighbors approach proposed by Haghverdi et al.
(2018) to calculate anchor cells in the CCA space between datasets and performs correction
via these anchor cells. Many similar approaches which generally involve projection to a
lower-dimensional space via matrix factorization and smoothing of similar cells were later
developed (Hie, Bryson, and Berger 2019; Korsunsky et al. 2019; Polański et al. 2019; Welch
et al. 2019). However, these methods fail to account for observed covariates besides batch
and cannot accommodate complex experimental designs. In addition, these methods have




Consider a data matrix X = {x(i)}Ni=1 where each sample, indexed by i, is a p-dimensional
vector with corresponding k-dimensional latent vector z and l-dimensional covariate vector
b with k, l  p. In the single-cell setting, x(i) represents the observed gene expression
vector for cell i, b(i) represents variables such as cell library size, sample batch, or subject
age that we want to correct for, and z(i) lies in a low-dimensional latent space that which
captures the underlying biological variation across cells that are of operational interest, such
as differences in cell type, differentiation stage, and other aspects of cell activity which we
wish to study. z(i) is unobserved and b(i) is observed. Our goals are two-fold. The first is
to find the low-dimensional z(i) which best represents x(i) after removing the effects of b(i).
We achieve this goal by encouraging b(i) and z(i) to capture separate sources of variation
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in x(i). The second is to provide a denoised approximation of the high-dimensional x(i) as
a function of z(i) without the variation associated with b(i).
Let xz,b denote the observed expression vector under observed covariates b and unknown
biological state z. For simplicity, we assume b and z have mean zero. We will first treat
the expectation of xz,b as a continuous function of z and b:
E(xz,b) = g(z,b)
= g(z,0) + h(z,b),
where g(z,0) = E(xz,0) is the mean expression of a cell in biological state z and experimental
condition b = 0, and h(z,b) = g(z,b)−g(z,0) is the difference in mean expression between
experimental conditions b and b = 0 for a cell in state z.
We can further decompose the function as
E(xz,b) = g(z,0) + h(z,b)
= g(z,0) + h(0,b) + δ(z,b),
where h(0,b) = g(0,b)− g(0,0) is the difference in mean expression between experimental
settings b and b = 0 for a cell with mean biological state z = 0. δ(z,b) = h(z,b)− h(0,b)
represents the difference in the effect of b on a cell in state z and the effect of b on a cell
in state z = 0. δ(z,b) can be thought of as the interaction between z and b and g(0,0) as
the intercept.
We can now write
E(xz,b) = g(z,0) + g(0,b)− g(0,0) + δ(z,b)
= E(xz,0) + E(x0,b)− E(x0,0) + δ(z,b)
(3.1)
We have decomposed E(xz,b) into a component which only depends on z, a component
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which only depends on b, an intercept term, and an interaction term. Note that this
reparameterization is flexible and can be applied to any continuous function g. In matrix
notation, we can write this as
E(X) = XZ + XB −X0 + XQ (3.2)
XZ represents the approximation of X based solely on Z without factoring in the knowledge
of B. There are several ways of learning Z and XZ which we describe below.
3.3.2. Linear Setting: Constrained Principal Components Analysis and Linear Autoen-
coders
For intuitive understanding of the methods presented, it is beneficial to first consider the
linear factor model
xz,b = a + Uz + Vb + ε,
where U and V are the factor loadings for the unobserved factors z and observed b respec-
tively and ε ∼ N (0,Ψ) for a diagonal covariance matrix Ψ.
One limitation of the standard linear factor model is that it assumes additivity between
Uz and Vb and no interaction. This means that the confounding variable b is assumed
to have the same effect on the observed x for every possible latent vector z. In reality,
this is oftentimes not the case especially in single-cell RNA sequencing experiments. For
example, the time elapsed since death of a subject until tissue processing, also known as
the post-mortem interval, has been found to affect the gene expression profiles in a tissue-
specific manner (Ferreira et al. 2018). Writing this in the notation presented, the effect of
post-mortem interval, bi, on the gene expression, xi, of cell i depends on the tissue, zi, even
though the samples may be harvested in a balanced design where post-mortem interval and
tissue are uncorrelated.
To allow for situations where the effects of the observed covariates on x may vary across
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levels of the latent factor, we consider the linear factor model with interactions
xz,b = a+ Uz + Vb + Wq + ε
where q = bRz, R ∈ IRl×k, and  is the element-wise product. R is a projection matrix
of z to the same dimension as b. Here, we are assuming the interaction term q is linear
in the components of b and z. Writing this in matrix notation, we can decompose the
observed data matrix as
X = A + ZUᵀ + BVᵀ + QWᵀ + E
= A + XZ + XB + XQ + E
(3.3)
This can be formulated under the general framework presented in section 3.3.1 where
g(Z,B) = E(A + XZ + XB + XQ)
g(Z,0) = E(A + XZ)
g(0,B) = E(A + XB)
g(0,0) = E(A)
δ(Z,B) = E(XQ)
In the case where Ψ is spherical and there are no interactions, constrained principal com-
ponents analysis (CPCA) (Takane and Hunter 2001) can be applied to recover the loading
matrix U and Z deterministically. Briefly, multivariate linear regression is performed to
project the observed data matrix X onto the linear subspace spanned by B and PCA is
applied to the residuals to recover Z as the top k principal components and U as the top k
principal loadings.
Thus, for a centered data matrix X ∈ IRN×p and observed centered covariates B ∈ IRN×l,
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the estimate provided by CPCA is
X̂
CPCA









Here, BΓ = B(BᵀB)−1BᵀX is the linear projection of X onto the subspace spanned by
B and Ẑ
CPCA
Uᵀk is the rank k approximation to the regression residuals X − BΓ. By
the Eckart–Young–Mirsky theorem (Eckart and Young 1936), X̂
CPCA
Z is the best rank k
approximation of X under the constraint that the subspace spanned by X̂
CPCA
Z is orthogonal
to the subspace spanned by B. In this way, X̂
CPCA
Z is the new representation of X which
is orthogonal to B.
To motivate our use of the conditional variational autoencoder, we will consider the deter-
ministic conditional linear autoencoder. Consider a data matrix X ∈ IRN×p. The autoen-
coder consists of a encoder function f : IRp → IRk and a decoder function g : IRk → IRp,
where the output is X̂ = g(f(X)) and the estimate for Z is Ẑ = f(X). The linear autoen-
coder (LAE) refers to one-layer encoder and decoder functions with linear activations such
that X̂ = XW1W2 and Ẑ = XW1. The loss function is
L(W1,W2) = ‖X−XW1W2‖2
It has been shown that the LAE finds the same subspace spanned by the first k principal
components of PCA (Baldi and Hornik 1989) and regularization on W1 and W2 is able to
recover the principal components themselves (Kunin et al. 2019; Plaut 2018).
In the case where we have observed factors B, we modify the LAE to incorporate B. For
the input to the encoder function f , we concatenate X and B such that
Ẑ
LAE




























B are rotation invariant with respect to the reconstruction
loss of X. To enforce orthogonality of X̂
LAE
Z to B, we consider a weighted loss function
where
Lα(f, g) = (1− α)
∥∥∥X− X̂LAE∥∥∥2 + α∥∥∥X− X̂LAEB ∥∥∥2
= (1− α)‖X− g(f(X,B),B)‖2 + α‖X− g(0,B)‖2
(3.4)
α = 0 corresponds to minimizing the reconstruction error, i.e., the standard linear au-
toencoder loss. With α > 0, WB2 is estimated as the multivariate regression coefficients
B(BᵀB)−1BTX. Thus, the direction of X̂
LAE
B is fixed to lie in the subspace of B which
encourages X̂
LAE
Z to lie in the null space. We show through simulation studies that this is
indeed the case.
3.3.3. α-CVAE
Instead of adopting a deterministic framework as above, we can model the relationship
between z, b, and x using a generative model. The variational autoencoder (VAE) (Kingma
and Welling 2013) is one such model which uses a neural network to capture the generative
process of x from latent variable z. The conditional variational autoencoder (CVAE) (Sohn,
Yan, and Lee 2015) is an extension to the VAE where additional observed variables b can
be conditioned on in the generative process. Here, we propose a modified version of the
CVAE, called α-CVAE, to encourage z and b to capture separate sources of variation in x
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using the weight parameter α.
In the variational autoencoder framework, the latent variable z is generated from a prior
distribution pθ(z) and the output x is generated from the distribution pθ(x|z,b). The true
posterior distribution pθ(z|x,b) is usually intractable so a parametric distribution qφ(z|x,b)
is used to approximate the posterior. In the α-CVAE, qφ(z|x,b) is the encoder and pθ(x|z,b)
is the decoder. The variational lower bound is defined as





The empirical objective can be written as:






where z(l) = fφ(x,b, ε), ε ∼ p(ε) and fφ(·) is a deterministic encoder function used in the
reparameterization trick. For the conditional variational autoencoder in this paper, we let
L = 1 and ε ∼ N (0, I).
Similar to above, we want z to capture variation in x which can not be explained by b. We
define the weighted empirical objective as
LV AEα (x,b; θ, φ) = −KL(qφ(z|x,b)||pθ(x))+(1−α) log pθ(x|z(1),b)+α log pθ(x|0,b) (3.7)
α is typically set to 0.1. After training, we can characterize the variational approximate
distribution qφ(z|x,b) as well as the generative distribution pθ(xz|z,b = 0). By setting
b = 0, we are recovering the matrix XZ which is corrected for b.
3.3.4. SAVER-CVAE
In single-cell RNA sequencing, consider the gene expression Y where each row represents
a cell and each column represents a gene. Each entry is an integer count of the number of
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RNA molecules present in that cell for that gene. The number of genes is typically around
20,000-30,000 and the number of cells can be anywhere from a few thousand to a million. B
is the cell-specific covariate matrix and can include covariates such as library size or sample
information like age or sex. As in the SAVER model presented previously, we assume each
observation Ycg ∼ Poisson(λcg), λcg ∼ Gamma(αcg, βcg). Note here that we do not include
the library size term sc in the Poisson mean, but instead model it as an observed covariate
in B. Our goals are to characterize the cells in a low-dimensional space via the latent vector
zc and denoise the expression counts using the empirical Bayes SAVER framework. We will
refer to this method as SAVER-CVAE.
We first characterize the posterior on the latent Z while removing the effects of B. We train
the α-CVAE to convergence by maximizing the weighted objective in equation 3.7 taking
the log expression of a subset of highly variable genes as the input and using a Poisson
distribution as the generative model for Y. We chose the Poisson distribution in this step
rather than the zero-inflated negative binomial distribution used in scVI (Lopez et al. 2018)
and DCA (Eraslan et al. 2019) due to some instability issues when training the negative
binomial loss to convergence. In addition, multiple studies (Chen et al. 2018; Hafemeister
and Satija 2019; Svensson 2020) have found that zero-inflation is not necessary to model
UMI-based single-cell data. For cell c, we let the variational approximate posterior be a
multivariate Gaussian with diagonal covariance parameterized by means µ̃(c) and variances
σ̃2(c) which are outputs of the encoder so that
z(c)|y(c),b(c) ∼ N (µ̃(c), σ̃2(c)I)
Once we have the posteriors of z(c) characterized, the second step is to denoise the expression
vector y(c). We want to predict the gene expression vector y(c) from z(c) while correcting
for b(c). We train a separate decoder network with z(c) ∼ N (µ̃(c), σ̃2(c)I) and b(c) as the
inputs to model the generative distribution p(y(c)|z(c),b(c)). The new empirical objective
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Figure 27: SAVER-CVAE method.
is without the KL term
Lα(y,b; θ) = (1− α) log pθ(y|z(1),b) + α log pθ(y|0,b) (3.8)
Here, we assume the generative distribution is negative binomial and the outputs of the
decoder are the negative binomial means µ(c) = gµ(z
(c),b(c)) and dispersions θ(c) =
gθ(z
(c),b(c)) for each cell c. In order to prevent overfitting, k-fold cross validation is per-
formed on the training to select the epoch which maximizes the valdiation likelihood. Once
the network is trained, the estimated matrices µ and θ represent the parameters of the
negative binomial distribution which maximizes the out-of-sample likelihood on Y. This is
similar to the Lasso prediction step of the SAVER procedure except we are simultaneously
estimating the gene- and cell-specific prior dispersion parameter in the SAVER-CVAE. This
removes the need to perform the marginal likelihood maximization step after deriving the
prior mean parameters in SAVER. To remove the effect of B, we set B = 0 in the network
input to get the new estimated µZ = gµ(Z,0) and θZ = gθ(Z,0). Figure 27 outlines the
procedure.
There are three approaches we can take with these new estimates. The first is to directly
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use the µZ as the denoised estimates. This is the strategy employed by scVI (Lopez et al.
2018). However, the previous chapter demonstrated that directly using the predictions often
overfits the data.
The second approach is to derive a new observed count matrix YZ by performing CDF
matching of Y ∼ NB(µ,θ) and YZ ∼ NB(µZ ,θZ). The intuition behind this is that we
want the distributional characteristics of the observed Y given the predicted µ and θ to be
identical to the distributional characteristics of our estimated YZ to the adjusted µZ and
θZ . Then, our estimate of YZ is defined as
YZ = F
−1(F (Y;µ,θ);µZ ,θZ) (3.9)
This preserves the technical noise characteristics of scRNA-seq expression count data af-
ter adjusting for the observed covariates. This is useful in downstream scenarios where
hypothesis testing on the original count data is desired, such as in differential expression.
The third approach is to apply the SAVER framework presented previously and derive the
SAVER posterior λZ |YZ . To do this, we first reparameterize the estimated µZ and θZ
as the shape αZ and βZ parameters of the prior Gamma distribution. Then, using our
estimate of YZ from equation 3.9, the empirical Bayes SAVER posterior is defined as
λZ |YZ ∼ Gamma(YZ +αZ ,1 + βZ) (3.10)










3.4.1. Weighted objective in LAE recovers CPCA solution
To motivate the weighted objective in our proposal, we compare the results obtained through
CPCA and the results through the linear autoencoder on simulated data generated from
the linear factor model presented in equation 3.3.
We assume our data matrix X, n = 3000, p = 1000, is composed of two low rank matrices:
XZ of rank k = 16 and XB of rank l = 4. For now, we assume X is centered and there is
no interaction term XQ. We model X, XZ , XB as follows:
X = XZ + wBXB + wEE = ZU
ᵀ + wBBV
ᵀ + wEE,
where E is the error matrix sampled from a standard Gaussian. Z was constructed by
sampling 1,000 observations from one of three 16-dimensional multivariate Gaussians with
overlapping means and identity covariance matrix for a total of 3,000 observations. In
this simulation, we assume that there are three batches and one continuous variable we
want to correct for. We randomly assigned each observation to one batch and sampled
the continuous variable from a standard uniform. Thus, B is a matrix with the first three
columns indicating batch assignment and the fourth column as the continuous variable
which we further standardized. The entries of weight matrices U and V as well as those of
the error matrix E were sampled from a standard normal. XZ and XB were standardized
and wB and wE were set to 1/3 and 2/3 respectively. The resulting X was also standardized.
We applied CPCA to X given B to estimate XZ as described above, setting k = 16. For
the single-layer conditional autoencoder, recall that the output is
X̂ = g(f(X,B),B) = g(Ẑ
LAE
,B),





































































Figure 28: a) MSE between X̂CPCA and X̂LAE as a function of α. b) MSE between X̂CPCAZ




B as a function of α.
number of nodes in the middle layer to be 16 as well. After learning Ẑ
LAE
, we can recover
XB = g(0,B) and XZ = g(Z,0).
To investigate the ability of the conditional linear autoencoder to recover the same solution
as CPCA, we applied both methods to the same simulated dataset and evaluated how




Z , and X̂
CPCA
B as estimated by CPCA.
Figure 28 shows the MSE between the estimated matrices found by the linear autoencoder
and the ones found by CPCA as a function of α, the weight on the loss using only B as
input as shown in equation 3.4. In recovering X, the overall discrepancy between CPCA
and LAE is extremely low, on the order of 10−6 (Fig. 28a). This is expected as both are
solving the L2 objective with respect to X given B. There is a slight increase in the MSE
from α = 0 to α = 0.1 but the difference is slight.
However, LAE fails to recover the CPCA estimates for XZ and XB at α = 0 (Fig. 28b-
c). This is due to the lack of orthogonality constraints in the vanilla conditional linear





B will not be orthogonal under α = 0. When α increases, the estimates of XZ and XB
from the LAE become closer to the estimates obtained by CPCA until becoming identical
up to optimization error for α ≈ 0.1. Intuitively, this makes sense as α > 0 corresponds to
finding the best projection of X onto the subspace spanned by B. By putting a positive
weight on the reconstruction of X given only B, orthogonality is enforced.
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3.4.2. α-CVAE captures interactions between latent and observed factors
In the model presented above, we simulated from the linear factor model with no interactions
between z and b. Here, we consider the linear factor model with interaction term XQ




Q was constructed as Q = BΛ, where Λ is a linear combination of the columns of Z. To
simulate Λ, we first represented Z as a concatenation of four submatrices Z = [Z1Z2Z3Z4].
We performed PCA on each Zi and took the first principal component as Λ1 and constructed
Λ = [Λ1 Λ2 Λ3 Λ4]. By doing this, the dimensionality of Z is reduced to the dimensionality
of B. Then, we constructed the interaction factor as Q = BΛ. Like before, we sampled
the weight matrix W from a standard normal and standardized the resulting XQ matrix.
Three choices for the weight of the interaction matrix wQ were considered: wQ = 0 corre-
sponding to the no interaction case, wQ = 0.3 corresponding to the low interaction case,
and wQ = 0.5 corresponding to the high interaction case. We performed 100 simulations
and apply CPCA and α-CVAE with α = 0 and α = 0.1 to X to recover XZ , XB, and in
the case of the α-CVAE, XQ. To evaluate the performance, we calculated the R
2 between
variable i of the actual matrix and variable i of the estimated matrix and took the average
across the 1,000 variables. Figure 29 compares the distribution of the average R2 between
selected matrix components across 100 simulations.
First, we evaluated how well each method estimates XZ , the matrix that is free from any
effects of B (Fig. 29a). Under the no interaction scenario, CPCA is able to estimate XZ
extremely well while the α-CVAE performs slightly worse but still has an average R2 above
0.95. This is to be expected as the dependence of X on Z and B is purely linear, and
thus can be solved efficiently using CPCA while the α-CVAE does not assume a linear
relationship. However, the introduction of an interaction matrix reduces the performance
of CPCA sharply while the α-CVAE is still able to reconstruct XZ . Unlike in the LAE
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Figure 29: Average R2 between estimated and actual matrix components across 100 sim-
ulations. a) Comparison of estimated XZ and actual XZ . b) Comparison of estimated
XZ and actual XQ. c) Comparison of estimated XQ and actual XQ. d) Comparison of
estimated XB and actual XB.
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simulation, α doesn’t seem to affect the recovery of XZ .
To understand why CPCA performs poorly when an interaction term is added, we compared
the average R2 between the estimated XZ and the actual interaction matrix XQ (Fig 29b).
As the strength of the interaction increases, a larger proportion of the variation in the
interaction matrix XQ is captured by X
CPCA
Z . α-CVAE is relatively robust to the increasing
strength of interaction although again, α does not seem to lead to substantially different
results.
Recall that for the α-CVAE with centered X and B, the estimated interaction matrix XQ
is
X̂Q = δ(X,B) = g(X,B)− (g(X,0) + g(0,X))
The presence of the estimated interaction δ is the result of the nonlinearity of the activation
function, σ(x + y) 6= σ(x) + σ(y). In Figure 29c, we see from the high average R2 that
the interaction term is indeed captured by the nonlinearities of the activation function in
the α-CVAE and that setting α = 0.1 seems to lead to more accurate estimation of the
interaction.
Finally, we evaluated how well the methods estimate XB, the component of X which is a
function of only the confounding variables B. Because CPCA explicitly projects X onto the
subspace spanned by B, the average R2 is high even for the scenario with interactions. For
the α-CVAE, the R2 is still on the order of 0.95-0.975 but we now see a difference between
setting α = 0 and α = 0.1. Setting α = 0.1 allows more more accurate reconstruction of
XB and is more robust to increasing interaction strength.
Now we turn our attention to the estimated latent matrix Z. Recall that samples in Z
were drawn from three 16-dimensional multivariate Gaussians that we will refer to as type.
We can visualize the samples in the low-dimensional space using t-SNE (Van Der Maaten
and Hinton 2008) to see the effect of the batch assignment on the type (Figure 30). In
the original Z, the samples are arranged into three separate clusters indicated by type with
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Figure 30: t-SNE visualization of simulated data comparing Z, X, CPCA, and α-CVAE.
random batch assignment. X contains the effects of batch through B which can be seen as 9
separate clusters for each combination of batch and type. As the strength of the interaction
increases, the clusters become more irregular. For the Z estimated from CPCA, we see
that CPCA effectively mixes the batches and recovers the original Z structure when there
is no interaction. However, when interaction between Z and B is introduced, the CPCA
estimated Z separates according to batch. α-CVAE with α = 0.1 is able to recover the
original Z and remove the batch effect even in the presence of high interaction.
From this simulation experiment, we found that CPCA does not effectively remove the
effects of B when there are interactions between B and the latent matrix Z. The α-CVAE
is able to capture the interactions through the nonlinearities in the activation functions
used in the decoder and can separate Z from B even in the presence of interactions.
3.4.3. Simulation based on empirical interaction effects
In the previous section, we showed that CPCA performs poorly when interaction effects are
large. However, it is unclear how prevalent and how strong interaction effects are in real data
examples. To explore this question, we analyzed single-cell RNA sequencing data collected
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on peripheral blood mononuclear cells (PBMCs) from three healthy donors. PBMCs have
been found to exhibit limited variation in healthy individuals (Whitney et al. 2003) so we
would expect the underlying cellular characteristics to be similar across the three donors.
Each donor was sequenced using three distinct technologies: 8,169 cells from 10X 5-prime
(VDJ) sequencing, 8,241 cells from 10X 3-prime version 2 (V2) chemistry, and 11,612 cells
from 10X 3-prime version 3 (V3) chemistry for a total of 28,022 cells and 22,431 genes after
filtering. Here, we treat technology as batch. The goal is to integrate across batches and
also correcting for the library size, which is the number of total RNA molecules sequenced
for a given cell.
PBMCs are known to consist of cells which broadly fall into three main cell types: mono-
cytes, T/NK cells, and B cells. To perform the simulation, we first log-transformed the data
to make it more normal. Then, we estimated the cell type-specific batch effect and library
size effect for each gene in the original dataset by fitting a linear model






where xgcb represents the log-normalized expression in cell type c and batch b for gene g,
Dcb is an indicator variable indicating cell type and batch assignment, and s is the library
size. In order to perform a simulation where we know the ground-truth for Z, we selected
a subset of 3,000 cells from the V3 dataset to serve as our corrected expression matrix XZ .
To create the simulated matrix X, we randomly assigned cells to a batch and library size
according to the empirical distribution in the original dataset. Based on the sampled batch
and library size, the empirical cell type-specific batch and library size effect was calculated
according to the estimated linear model and was added to XZ to simulate X. Thus, for cell









This way, the simulated X has similar effects due to interaction as the observed data matrix
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Figure 31: t-SNE visualization of simulated PBMC data Z, X, CPCA, and α-CVAE.
and we can compare the estimated XZ from CPCA and α-CVAE to the real XZ .
First, consider embeddings of the latent space using t-SNE (Figure 31). For the actual Z,
the cells cluster into three main cell types and well mixed across batch, as expected since
in our data generation, batch was randomly assigned to each cell. For X, which depends
on both Z and batch, the clusters separate according both batch and cell type. CPCA is
able to recover roughly the original cell types, but within each cell type, patterns associated
with batch can still be seen. This indicates that the original data had strong interactions
between cell type and batch. α-CVAE using α = 0.1 is able to recover the main cell types
while removing batch within each cell type.
Next, we looked at the estimated X̂Z from CPCA and α-CVAE to investigate whether the
effects of batch and library size were effectively removed in the high-dimensional matrix.
To test the thoroughness of batch correction, we used the Anderson-Darling k-sample test
(Scholz and Stephens 1987) to test, for each gene, whether its observations across the three
batches are randomly sampled from the same unspecified distribution. We conducted the
Anderson-Darling test for each gene. Here, we would want the corrected X̂Z matrix to have






















































































































































































































































































































































































































































Figure 32: Evaluating the removal of batch and library size effects for each cell type and all
cells in the PBMC simulated dataset. a) Anderson-Darling p-values across genes testing for
differences in batch. b) Pearson’s R between log10 library size and expression prediction.
similar.
Figure 32a shows the distribution of p-values from the Anderson-Darling test for all genes
across the three cell types and for all cells. A small p-value indicates strong evidence that
the samples came from different distributions. For the true XZ , the distribution of p-values
is tightly concentrated between 0.01 and 1. This is to be expected since XZ is independent
of the simulated batch so the test statistics should follow the null distribution. On the
other hand, when we look at the simulated X, the majority of genes have p-values smaller
than 10−25 for monocytes and T/NK cells and smaller than 10−10 for B cells. X̂
CPCA
Z also
contains genes with p-values on the order of 10−25 and 10−10. The output of α-CVAE with
both α = 0 and α = 0.1 contains p-values concentrated between 0.01 and 1, similar to the
ground truth.
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Figure 32b shows the distribution of the Pearson’s correlation between log10 library size and
each gene. For the true data matrix XZ , the correlations are mostly concentrated around 0.
The correlations for the simulated X are substantially higher and have much larger variation
lying mostly between 0 and 0.4. For CPCA, the correlation calculated across all cell types
is essentially zero. However, within each cell type, the correlations obtained from CPCA
have tremendous variation ranging from -0.5 and 0.5. This is the result of CPCA directly
removing the effect of library size globally across all cells but not within each cell type due
to interaction effects. Finally, α-CVAE produces correlations consistent with those of the
true XZ .
For the Anderson-Darling tests, α = 0.1 seems to give better batch correction than α = 0
while for the correlation between library size and expression, α = 0 performs slightly better
than α = 0.1. We suspect that there is not much difference in performance across α for
the α-CVAE as compared to the case in the linear autoencoder because we included batch
normalization in the encoder layers for α-CVAE. Batch normalization adds sampling noise
to each layer output due to stochastic mini-batch training. This appears to regularize the
neural network and encourages orthogonalization between Z and B. However, based on
the results for the LAE and the linear factor model simulations, we recommend setting α
greater than 0 for increased interpretability.
3.5. Applications to Single-Cell RNA Sequencing
We have shown thus far that the α-CVAE with α = 0.1 can correct for effects from con-
founding variables even under the presence of interactions. We now apply the SAVER-CVAE
presented in section 3.3.4 to single-cell RNA-seq datasets. Recall the difference between the
SAVER-CVAE and the α-CVAE analyzed in the previous section is the use of the Poisson
distribution to first model the posterior of Z and the use of the negative binomial distribu-
tion to denoise and output the negative binomial mean and dispersion parameters for each
gene while adjusting for B.
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Figure 33: Moving average of the improvement in gene-wise correlations with reference of
SAVER, SAVER-X, and SAVER-CVAE recovered datasets and gene-wise correlations with
reference of down-sampled datasets.
3.5.1. Down-sampling Experiment
In Chapter 2, we presented a down-sampling experiment to evaluate the effectiveness of
SAVER (Huang et al. 2018) in recovering the true expression levels of four scRNA-seq
datasets. Briefly, highly expressed genes in high quality cells were selected in each dataset to
serve as the reference or true expression levels. Down-sampling was performed by sampling
from a Poisson distribution with the true expression multiplied by a cell-specific efficiency
factor ranging from 5% to 10%. SAVER and other denoising algorithms were evaluated by
comparing how similar the denoised dataset was to the reference dataset.
We applied SAVER, SAVER-X (Wang et al. 2019), and SAVER-CVAE to the four down-
sampled datasets and calculated the gene-wise correlation with the reference data. For
SAVER-CVAE, we used the posterior means as the estimates (Eq. 3.11) after correcting
for library size through B. We compared the difference between the gene-wise correlations
of the denoising methods and the gene-wise correlations of the down-sampled data. We
would want to see an improvement in the gene-wise correlations of the denoised datasets
over the down-sampled. Figure 33 compares the moving average across 100 genes of the
improvement in correlation as a function of the down-sampled correlation with reference. In
all four datasets, SAVER, SAVER-X, and SAVER-CVAE increase the gene-wise correlation
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Figure 34: Density plots of the Pearson’s correlation of library size and gene expression for
library size normalization, sctransform, and SAVER-CVAE counts YZ .
with the reference, with the magnitude of improvement first increasing as a function of
the down-sampled correlation and then slowly decreasing. However, for all genes, all three
denoising methods have correlations at least as high as the down-sampled data and have
large improvements for most genes. This indicates that for genes that have low signal,
i.e. low correlation with reference, the denoising methods are not able to improve greatly
over the down-sampled although they do not perform worse. For genes that have moderate
correlation with reference, the denoising methods are able to extract the signal and improve
the correlation. SAVER-CVAE seems to increase the correlation with the reference the
most for all four datasets. This demonstrates that by accounting for library size through
the observed covariate matrix b and through the flexible modeling of the dispersion term,
SAVER-CVAE is able to extract more signal from scRNA-seq data.
To further investigate the effects of modeling library size through B, we compared the
SAVER-CVAE corrected counts YZ with library size normalization and sctransform (Hafe-
meister and Satija 2019) in correcting for library size in the four down-sampled datasets.
sctransform is an scRNA-seq normalization technique using regularized negative binomial
regression to regress each gene on the log of the library size. Recall that the SAVER-CVAE
corrected counts are derived through the CDF matching procedure. We calculated the
Pearson’s correlation of each gene with the log10 of the library size (Figure 34). For all
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Figure 35: Visualization of cells in the PBMC complete dataset comparing Seurat, scVI,
and α-CVAE.
four datasets, library size normalization and sctransform produce correlations between -0.1
and 0.1. The correlations of the SAVER-CVAE counts YZ are more concentrated around
0, with the majority of correlations between -0.05 and 0.05. This indicates that SAVER-
CVAE is effectively able to remove the effects of library size for each gene by correcting for
library size through the observed covariate matrix B. There is a slight bias towards positive
correlations in the La Manno and Zeisel datasets although the correlations are still small.
This might be due to the fact that library size is thought to be affected by both technical
noise and biological factors such as cell size. Genes with a slight positive correlation with
library size might scale with cell size. In addition, the positive bias in correlations might
indicate a dependence of gene expression on library size may that is not purely explained
by linear scaling.
3.5.2. PBMC dataset
First, we looked at the original PBMC count data consisting of 28,022 cells and 22,431 genes
sequenced with three distinct technologies/batches. We wanted to evaluate the performance
of the SAVER-CVAE with other single-cell batch removal methods Seurat (Stuart et al.


























































































































































































































































































































































































































































































































































































































































































































































































Figure 36: Evaluating the removal of batch and library size effects for each cell type and
all cells in the PBMC complete dataset for the original, Seurat, scVI, YZ , and SAVER-
CVAE posterior datasets. a) Anderson-Darling p-values across genes testing for differences
in batch. b) Pearson’s R between log10 library size and expression prediction
data and visualized the cells in low dimension using UMAP (McInnes et al. 2018), a method
similar to t-SNE (Fig. 35). Like the PBMC simulated data, the original data Y exhibit
severe batch effects with cells clustering by both cell type and batch. Seurat, scVI, and
the SAVER-CVAE all are able to recover the three main cell types and the batches appear
well mixed within each cell type. This is not too surprising as the cell types are strongly
separated in the latent space, and thus the correction problem is relatively easy.
However, most single-cell batch correction methods focus on alignment of cells in a low-
dimensional space and do not evaluate their performance in correcting and denoising the
output. Here, like in the previous section, we assessed each method’s ability to produce an
estimated expression matrix in high dimension that is corrected for batch via the Anderson-
Darling k-sample test and corrected for library via the correlation with log10 library size
(Fig. 36). 5,000 cells and 1,000 genes were randomly selected for this analysis.
We plotted the distribution of p-values for the original data Y, the Seurat corrected expres-
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sion matrix, the scVI corrected zero-inflated negative binomial means, the SAVER-CVAE
corrected count matrix YZ , and the SAVER-CVAE corrected posterior means (Fig. 36a).
For the original data, the median p-value is above 0.01 for all cell types although approx-
imately 20%, 8%, and 3% of all genes have p-values less than 10−6 for monocytes, T/NK
cells, and B cells respectively. This indicates that the batch effect affects a small subset
of genes but these genes end up driving the main differences in the UMAP visualization
for the original data. For the Seurat output, the majority of genes have p-values less than
10−50, 10−100, and 10−25 for monocytes, T/NK cells, and B cells respectively. Similarly, for
scVI, the majority of genes have p-values less than 10−10 with the exception of B cells. In
contrast, both YZ and SAVER have p-values greater than or centered around 0.01, with
very few p-values less than 10−10. The SAVER output has slightly lower p-values than YZ .
This can be attributed to SAVER being the corrected denoised matrix, which has stronger
signal and greater sensitivity to differences between batch than the corrected noisy count
matrix YZ . However, we want to emphasize both YZ and SAVER are able to correct for
the batch effects more effectively than other methods. The correlation between log10 library
size and gene expression are relatively similar across methods except scVI which has the
highest range of correlations. (Fig. 36b). The correlations of scVI are centered around
zero as calculated across all cells but are positively biased for monocytes and negatively
biased for T/NK cells and B cells. This indicates that scVI does not effectively normalize
for library size within each cell type.
As an example of gene-level distributions, consider the genes ALDOA, CXCR4, HNRNPA1,
which were found to exhibit large batch effects. We plotted the densities of the expression of
these genes for the original data Y, Seurat, scVI, the CDF-matching corrected counts YZ ,
and the corrected SAVER-CVAE posterior means (Figure 37). For the original Y, we see
that batch effects are quite varied between different genes and the different cell types. The
corrected expression from Seurat has a bimodal distribution and differences in batch are
quite apparent within cell types. This explains the poor performane of the Seurat-corrected
expression values in the Anderson-Darling tests. scVI does a better job of aligning the
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Figure 37: Density plots for the gene expression of ALDOA, CXCR4, HNRNPA1 in PBMC
data.
gene expression of the batches with each cell type but the gene expression distributions are
markedly different from the original expression distributions. On the other hand, YZ and
SAVER-CVAE exhibit similar distributional characteristics as the original data with much
better agreement in distribution among the batches, with SAVER-CVAE showing better
alignment of batches. In addition, YZ and SAVER-CVAE are on the same scale as the
original data unlike Seurat and scVI.
3.5.3. Application to Alzheimer’s data
The analysis in the preceding sections have shown that, given a set of covariates, SAVER-
CVAE can learn a low-dimensional latent representation of the data with the effect of these
covariates removed. However in real applications it is often unclear which covariates to
adjust for and how exactly to perform the adjustment. The flexibility of our proposed
SAVER-CVAE is that it can accommodate complicated experimental designs and adjust
for continuous covariates, which other batch correction and denoising methods do not ac-
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Patient Batch Age (yrs) Sex Diagnosis ApoE PMI (hrs)
AD1 A1/A2 91.0 M AD NA 8.0
AD2 A1/A2 83.8 M AD E3/E4 10.0
AD3 A3/A4 67.8 F AD NA 21.0
AD4 A3/A4 83.0 F AD E3/E3 34.0
AD5 A5/A6 73.0 M AD E4/E4 9.5
AD6 A5/A6 74.6 M AD E3/E4 30.0
Ct1 C1/C2 67.3 F Ct E3/E3 24.0
Ct2 C1/C2 82.7 F Ct E3/E3 28.5
Ct3 C3/C4 72.6 M Ct E3/E3 42.5
Ct4 C3/C4 75.6 M Ct E3/E4 46.0
Ct5 C5/C6 77.5 M Ct E3/E3 53.5
Ct6 C5/C6 82.7 M Ct E2/E4 27.0
Table 3: Alzheimer’s disease dataset patient information.
comodate. To illustrate the considerations needed in performing covariate adjustment, we
examined an Alzheimer’s dataset from Grubman et al. (2019). In this study, Grubman
et al. (2019) collected single-nucleus RNA-seq data from the entorhinal cortex region of the
brains of six human patients with Alzheimer’s disease and six control subjects. Patient
characteristics can be found in table 3.
Grubman et al. (2019) were interested in studying the differences in cell-type specific gene
expression between Alzheimer’s patients and control subjects and identifying differentially
expressed genes (DEGs). We see from table 3 that there are possible confounding covari-
ates which may affect the analysis. For example, patients with Alzheimer’s disease have
substantially shorter PMI, or post-mortem interval, than the control subjects. However,
the most glaring confounder is batch. For each batch, two patients were sequenced but they
were either both Alzheimer’s patients or both control. By performing the experiment in
this fashion, batch is completely confounded with the question of interest — the difference
between Alzheimer’s patients and control subjects. From the tSNE plots in Figure 38, we
see that while there are large differences between batches for the Alzheimer’s patients, there
are visually noticeable differences even between batches which contain only control subjects.
A more appropriate design would have involved sequencing one Alzheimer’s patient and one
control patient in each batch to effectively control for batch effects and to perform com-
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parisons within batch. Due to this extreme confounding, naively aligning samples across
all batches, tactics often advocated in single-cell batch correction methods, would lead to
uninterpretable downstream identification of DEGs. Thus, a more careful consideration of
which variables to adjust for and how it would affect the interpretability of downstream
results is necessary.
We applied the SAVER-CVAE to this data under three adjustment schemes, ranging from
slight adjustment to large adjustment. In the slight adjustment scenario, we adjusted for
age, sex, and library size. The rationale was to identify surrogate variables which might
remove the effects of batch without explicitly correcting for batch, which would remove
the differences associated with diagnosis. Age, sex, and library size are primary candidates
for surrogate variables as these are probably uninteresting for investigating gene expression
differences. In fact, Grubman et al. (2019) attempted to match Alzheimer’s patients and
control subjects on age and sex. For the moderate adjustment scenario, we adjusted for
PMI, as well as age, sex, and library size. PMI is also a variable that researchers would
control for if they were able to. However, the risk of adjusting for PMI in this experiment
is that it is strongly correlated with diagnosis (Table 3). Thus, the researchers must decide
whether they are willing to discover DEGs which might be driven by differences in PMI
rather than diagnosis. If the researchers want to be conservative and only find DEGs
which are orthogonal to PMI, adjusting for PMI would be recommended. However, if the
researchers are interested in extracting more signal and can accept the discovery of DEGs
which may be caused by differences in PMI, then not adjusting for PMI and only adjusting
for age, sex, and library size in the slight adjustment scenario would be more appropriate.
Finally, in the large adjustment scenario, we adjusted directly for batch and library size to
serve as a benchmark, since this is similar to what current batch correction methods do.
Grubman et al. (2019) did not attempt to remove the effects of batch in their analysis of
the data, most likely due to the confounding between batch and diagnosis.
First, we visualized the latent space of the cells of the original count matrix Y as well
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Figure 38: UMAP visualization of Alzheimer’s dataset cells colored by cell type, batch,
and diagnosis for the original data, slight adjustment, moderate adjustment, and large
adjustment by SAVER-CVAE.
as the SAVER-CVAE adjusted latent matrix Z under the three scenarios colored by cell
type, batch, and diagnosis (Figure 38). The cell type labels were identified by Grubman
et al. (2019) using cell type-specific marker genes. For the original data Y, cells generally
cluster according to cell type. However, within cell types, especially oligodendrocytes and
astrocytes, there are well-separated clusters of cells which are explainable by batch. This
results in the visual separation of diagnosis within each cell type. When we look at the
visualization of SAVER-CVAE under slight adjustment where we correct only for age, sex,
and library size, we see that the cell types separately cleanly. Unlike the original data,
there is a clear mixing of the batches within each cell type by diagnosis. For example, the
cells in batch AD1/AD2 colored red and the cells in batch AD3/AD4 colored yellow are
completely separated in the original data for oligodendrocytes. After correcting for only
age, sex, and library size, the cells in these two batches are visually very well mixed. Notice
there is still a separation of diagnosis. When we look at the visualization of SAVER-CVAE

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 39: Anderson-Darling k-sample test of differences in batch within each diagnosis
condition for each cell type for original, YZ , and SAVER-CVAE posteriors under slight (S),
moderate (M), and large (L) adjustments.
preserved but now, all batches are visually mixed even between Alzheimer’s diseased cells
and control cells. Thus, correcting for PMI, which is correlated with diagnosis, removes a
substantial amount of variation which was previously attributed to differences in diagnosis.
Finally, when we correct for batch and library size in the large adjustment scenario, we see
that batch and diagnosis are well mixed as expected.
Next, we wanted to see the degree at which batches under each diagnosis are mixed for
the denoised expression matrix. We applied the Anderson-Darling k-sample test to each
gene testing for differences in gene expression between each batch per diagnosis (Figure 39).
Consistent with the findings of the PBMC data, the majority of genes in the observed data
have p-values greater than 0.01, while small subsets of genes have extremely low p-values
especially for oligodendrocytes as confirmed through the UMAP visualization in figure 38.
These subsets of genes drive the batch effect. By adjusting for age, sex, and library size
in the slight adjustment scenario, genes with extremely low p-values have been eliminated,
although more so in YZ than in the SAVER-CVAE output. Again, since the SAVER-
CVAE output is denoised, it is able to extract signal in the differences between batches
in this scenario since batch is not explicitly corrected for. Looking at the distribution of
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Original YZ (S) YZ (M) YZ (L) S−CVAE (S) S−CVAE (M) S−CVAE (L)











Figure 40: Density plots for the gene expression of LINGO1 in oligodendrocytes.
p-values under the moderate adjustment scenario, where we also adjust for PMI, we see
that the distribution of p-values is shifted towards larger values, indicating that adjusting
for PMI is able to correct for batch effects within each diagnosis condition. Finally, directly
adjusting for batch and library size in the large adjustment scenario leads to a distribution
of the largest p-values which is to be expected as batch is being explicitly corrected for.
To visualize the effects of the correction under each scenario, we compared the distribution
of expression of the gene LINGO1 across batches (Fig. 40). Grubman et al. (2019) found
LINGO1 to be differentially expressed between Alzheimer’s cells and control cells in oligo-
dendrocytes. In the original data, we see that the control batches have relatively similar
expression distributions while batch AD1/AD2 contains cells with substantially higher ex-
pression than batches AD5/AD6 and AD3/AD4. The expression in batch AD3/AD4 more
closely aligns with the expression in the control subjects. Adjusting for age, sex, and li-
brary size under the slight adjustment scenario removes the major differences in expression
between batches within diagnosis although differences between Alzheimer’s and control are
still apparent. The addition of PMI to the adjustment in moderate adjustment results in
very similar expression distributions between batches in Alzheimer’s and control with the
exception of batch AD5/AD6. Adjusting for batch and library size in the large adjustment
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Source Astrocyte Endothelial Microglia Neuron Oligodendrocyte OPC
Original 263 4 29 41 287 62
YZ (S) 65 5 14 2 57 21
YZ (M) 17 1 3 0 1 4
YZ (L) 1 1 1 0 0 0
S-CVAE (S) 906 114 215 12 685 603
S-CVAE (M) 250 9 7 1 5 0
S-CVAE (L) 51 5 0 2 17 0
Table 4: Number of differentially expressed genes between Alzheimer’s patient cells and
control cells for each cell type.
scenario leads to essentially identical expression distributions across all batches.
Finally, we analyzed the effect of the different scenarios of covariate adjustment on the
detection of differentially expressed genes (DEGs) (Table 4). We used the non-parametric
Wilcoxon rank-sum test to test for differences in distributions in gene expression between
Alzheimer’s patient cells and control cells in each cell type. Genes with a Benjamini-
Hochberg adjusted p-value of less than 0.01 and a log2 fold change of greater than 0.5 were
classified as differentially expressed.
In the original data, 263 DEGs were found for astrocytes, 287 DEGs were found for oligoden-
drocytes, while the rest of the cell types had less than 100 DEGs. In the slight adjustment
scenario, a lower number of DEGs were found per cell type in YZ than the original data,
with only 65 DEGs detected in astrocytes and 57 DEGs detected in oligodendrocytes. The
SAVER-CVAE output however detected a far larger number of DEGs per cell type, with
906 detected in astrocytes and 685 detected in oligodendrocytes. This is the product of
the denoising procedure being able to detect differences between Alzheimer’s and control
cells with greater power. This indicates that age and sex are not fully able to capture the
variation caused by bath. In the moderate adjustment scenario, an even lower number of
DEGs were found for YZ as compared to the original data with only 17 DEGs detected for
astrocytes and only 1 detected for oligodendrocytes. For the SAVER-CVAE output, 250
DEGs were detected for astrocytes and 5 were detected for oligodendrocytes. This indi-
cates that adjusting for PMI not only reduces the variation due to diagnosis at the latent
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level but also at the high-dimensional gene expression level. Not surprisingly, correcting for
batch and library size leads to the most conservative number of DEGs detected. For YZ ,
only 1 DEG was detected for astrocytes and 0 were detected for oligodendrocytes. The
SAVER-CVAE output only detected 51 DEGs for astrocytes and 17 DEGs for oligoden-
drocytes. Thus, explicitly correcting for batch in this case eliminates most of the signal
between Alzheimer’s diseased cells and control cells.
3.6. Discussion
Batch effects are only one type of observed technical covariate that needs to be corrected for
in single-cell RNA-seq studies. In this work, we presented a modified conditional variational
autoencoder, called α-CVAE, for removing batch effects as well as other observed covari-
ates while performing latent representation and denoising. We discovered that a weighted
objective function in the conditional linear autoencoder allows the recovery of the solution
provided by constrained principal components analysis. Further, we demonstrated in the
linear factor model with interactions that the α-CVAE is able to capture interactions be-
tween the unknown latent factors and the observed covariates via the nonlinear activation
functions in the neural network. This result reveals how careful construction of neural
networks can allow them capture and disentangle latent factors into separate components.
Next, we presented SAVER-CVAE, a framework for latent representation and denoising
of single-cell RNA-seq data while adjusting for covariates. We demonstrated improved
performance over existing batch correction methods in removing batch effects from the
expression matrix as well as its ability to correct for library size while denoising. Finally, we
applied the SAVER-CVAE to an Alzheimer’s dataset with large confounding and compared
different strategies for covariate adjustment.
SAVER-CVAE is computationally efficient. For the Alzheimer’s dataset of 12,770 cells and
10,850 genes, the characterization of the latent representation took 40 minutes and the
estimation of the prior parameters for denoising took 20 minutes. For the PBMC dataset
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of 28,022 cells and 22,431 genes, the characterization of the latent representation took 1.5
hours and the estimation of the prior parameters took 1 hour. Both datasets were run using
8 CPUs with a total of 36 GB RAM.
One limitation of our method is that its main function is to remove the effects of observed
variables. However, one can imagine an extension where all variables, including the variable
of interest, is modelled as a latent factor and a joint model of both uninteresting and
interesting variables is formulated. This is similar to including all variables in a multiple
regression and testing for the significance of certain variables controlling for other variables.
The problem with applying this in the α-CVAE is that there is no simple corresponding
notion of orthogonality for nonlinear manifolds. Thus, the effect of collinearity of variables
is unknown for the α-CVAE. Another limitation is the size of the interaction between the
unobserved latent factors and the observed factors. In the linear model with interaction
simulation, we observed that the α-CVAE performed worse at high interactions than low
interactions. Investigating what exactly leads to the degradation in performance is an
interesting research direction.
There are a few takeaways from this work. The first is that naively correcting for batch
is oftentimes not the best approach especially in clinical studies and experimental settings
where the question of interest may be directly confounded with batch. A more careful and
systematic consideration of how observed technical covariates affect an analysis needs to be
conducted. The second is that the choice of which variables to correct for depends largely
on the context of the experiment. In the Alzheimer’s data, we saw how correcting for post-
mortem interval, a variable which is correlated with diagnosis, improves adjustment for
batches but reduced the power to detect differentially expressed genes. Thus, it is up to the
researcher to determine how stringent the correction should be in debating the classic trade-
off between sensitivity and specificity. Finally, a greater emphasis on experimental design
should be made at the beginning of the study to prevent having to correct for confounding
during analysis. Although we have shown the capability of our method to adjust for observed
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covariates, a balanced study would ultimately lead to more interpretable and reproducible
findings.
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CHAPTER 4 : Discussion
The motivation behind this thesis was to develop methods to remove technical noise from
single-cell RNA sequencing data while recovering true biological signal. The first paper pre-
sented the empirical Bayes framework and denoising method SAVER. Careful estimation of
prior parameters allows SAVER to denoise the gene expression matrix by borrowing strength
across genes. In addition, accounting for estimation uncertainty through the posterior dis-
tribution is critical for making reasonable conclusions through downstream analyses. Proper
post-denoising inference should be considered as a future research topic for more principled
usage of SAVER in scRNA-seq experiments. As an extension of SAVER, SAVER-X (Wang
et al. 2019) was developed to incorporate transfer learning from pre-trained models. The use
of an autoencoder to generate the prior gamma distribution allows for enhanced scalability
and computational efficiency over the nodewise Lasso regression.
One drawback of the SAVER and SAVER-X methods is that they do not incorporate the
modeling of covariates besides library size. Library size was directly corrected for by normal-
izing each cell by its library size. The second paper built on the SAVER framework to allow
for integration of observed technical covariates including library size, batch, and sample
characteristics into the model. We proposed a modified conditional variational autoencoder
called α-CVAE which uses a weighted objective function to estimate latent factors in the
presence of observed technical covariates. Further investigation is required to understand
how the interactions between the latent factors and observed covariates are captured in the
nonlinear activation function. We then incorporated the α-CVAE in the SAVER framework
with a method called SAVER-CVAE and demonstrated its ability to perform dimension re-
duction and denoising of scRNA-seq data while adjusting for observed covariates. With a
good experimental design, SAVER-CVAE allows true biological variation of interest to be
retained while removing technical noise and unwanted confounding variation.
The goal of denoising scRNA-seq data is to allow for greater signal in downstream analyses
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such as cell type identification, differential expression, and cell trajectory. This reduces the
number of cells that needs to be isolated as well as the required sequencing depth. This has
particularly large impacts in clinical studies where a limited number of cells can be acquired
from patients or in large-scale consortiums where sequencing costs are a major issue. The
advantage of the SAVER framework over other denoising methods is its ability to only
extract meaningful signal in the data. When there is no meaningful signal, the SAVER
results will behave almost identically to the observed data as to not introduce artificial
signal.
Although SAVER and SAVER-CVAE were developed with applications to scRNA-seq data
in mind, the concepts introduced in both methods can be broadly applied. The empirical
Bayes framework where informative prior parameters are constructed using the correlation
structure of a matrix may find applications in other matrix denoising problems. SAVER-
CVAE leverages the function fitting flexibility of deep neural networks to incorporate the
modeling of observed covariates. This can be applied to general factor analysis and dimen-
sion reduction problems.
A possible future direction of this work is in integrating high-dimensional data of different
modalities. Single-cell RNA sequencing data is one of many methods to investigate the
biology in single cells. Other methods include single-cell DNA sequencing, chromatin acces-
sibility, protein abundance, and spatial transcriptomics and proteomics. Each one of these
methods captures unique sources of biological function. The question of how to leverage
findings from these different data sources in the same experiment is largely unanswered.
SAVER-CVAE proposes a flexible deep learning framework where the input dataset and
output parameters are of the same data type. It would be interesting to investigate the
ability to adapt such a framework to incorporate multiple data types while jointly estimating
a shared latent representation.
An underlying theme in this thesis has been on how to perform denoising without introduc-
ing false signal. In the SAVER framework, the risks of overfitting are mitigated through
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cross-validation when performing the Lasso regression. Observed technical covariates which
can contribute to spurious downstream results are corrected for by SAVER-CVAE. Gener-
ation of the empirical Bayes posterior distribution helps quantify estimation uncertainty.
Embracing uncertainty rather than disregarding it allows for more reproducible research.




Let Ygc be the observed count of gene g in cell c. We can model Ygc as a function of a
cell-specific normalization constant sc and a true expression λgc. We place a Gamma prior
on λgc.
Ygc ∼ Poisson(scλgc)
λgc ∼ Gamma(αgc, βgc)
Let µ be the mean and v be the variance of a Gamma-distributed random variable X ∼







Instead of parameterizing by α and β, we can reparameterize in terms of the moments µ
and v:








µgc is obtained by fitting a Lasso Poisson regression as described in the Methods. Next,
we want to estimate vgc. We assume that for a given gene g, there is an underlying mean-
variance or dispersion relationship common to that gene. The following are three scenarios
which we consider:
1. Constant variance: vgc = vg
2. Constant Fano: vgc = Fgµgc
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Under this scenario, we assume that all the cells for a particular gene share a variance vg
which is independent of the mean. This independence implies that the predicted values are










To find vg, we need to maximize the marginal likelihood of Ygc given µgc and vg. Here,























































































We find the v̂g which maximizes this likelihood using the optimize function in R.
Constant Fano Factor
Under the constant Fano factor assumption, we assume that the variance scales linearly
with the mean. This corresponds with assuming the distribution of a gene is Poisson-like
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Thus, assuming a constant Fano factor is equivalent to assuming a constant rate βg param-
eter in the usual Gamma distribution parametrization. Therefore, we have the following
prior and want to find βg.
λgc ∼ Gamma(µgcβg, βg)




Ygc log sc − log Ygc! + µgcβg log βg − log Γ(µgcβg)
+ log Γ(Ygc + µgcβg)− (Ygc + µgcβg) log(sc + βg)
For numerical stability, we maximize with respect to 1/βg to get β̂g.
Constant Coefficient of Variation
Under the constant coefficient of variation assumption, we assume that the variance scales
quadratically with the mean. This corresponds to a typical constant scaling of a Gamma
distribution, since scaling by a constant c still gives a Gamma distribution with mean scaled







Thus, assuming a constant coefficient of variation is equivalent to assuming a constant shape
αg parameter in the usual Gamma distribution parametrization. Therefore, we have the












Ygc log sc − log Ygc! + αg logαg − αg logµgc − log Γ(αg)






For numerical stability, we maximize with respect to 1/αg to get α̂g.
Estimating v̂gc
For gene g, let lv(v̂g), l
F (β̂g), and l
cv(α̂g) be the maximized marginal likelihoods under
constant variance, constant Fano factor, and constant coefficient of variation respectively.
To find the noise model that corresponds to gene g, we take the maximum of lv(v̂g), l
F (β̂g),
and lcv(α̂g).
If the maximum is lv(v̂g), then we assign a constant variance model for gene g and let
v̂gc = v̂g.
If the maximum is lF (β̂g), then we assign a constant Fano factor model for gene g and let
v̂gc = µ̂gc/β̂g.
If the maximum is lcv(α̂g), then we assign a constant coefficient of variation model for gene
g and let v̂gc = µ̂
2
gc/α̂g.
A.2. Derivation of γg







Let Z = {Yg,Yg′ ,αg,αg′ ,βg,βg′}. Given Z, λg and λg′ are independent. By the law of
total covariance and independence,
Cov(λg,λg′) = E[Cov(λg,λg′ |Z)] + Cov[E(λg|Z),E(λg′ |Z)]
= Cov(λ̂g, λ̂g′)
In addition, by the law of total variance,
Var(λg) = Var[E(λg|Z)] + E[Var(λg|Z)]
= Var(λ̂g) + E[Var(λg|Z)]





























γg takes into account the posterior variance through E[Var(λg|Z)]. Thus, if the expected
posterior variance across cells is high compared to the variance of the estimates, then γg
will be small and
∣∣Cor(λg,λg′)∣∣  ∣∣∣Cor(λ̂g, λ̂g′)∣∣∣. However, if the expected posterior
variance across cells is small compared to the variance of the estimates, then γg ≈ 1 and∣∣Cor(λg,λg′)∣∣ ≈ ∣∣∣Cor(λ̂g, λ̂g′)∣∣∣
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Figure 41: Scatterplot of BABAM1 and LMNA for FISH (left), unadjusted SAVER (center),
and adjusted SAVER (right). The smooth scatterplot for the adjusted SAVER was created
by sampling from the posterior distribution for each cell.
In calculating the sample adjusted correlation, we have the expression









and the subscript s represent sample estimates.
Example
As an example, we will take a look at the effect of taking into account the adjustment factor
in calculating correlation between BABAM1 and LMNA (Fig. 41).
The correlation between BABAM1 and LMNA in FISH is 0.67. When we calculate the cor-
relation in the SAVER estimates as Cors(λ̂BABAM1, λ̂LMNA), we get a value of 0.92. Taking
the posterior uncertainty into account, we calculate the adjustment factor as γ̂BABAM1 =
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0.81 and γ̂LMNA = 0.93, so the adjusted correlation is
radj = γ̂BABAM1γ̂LMNACors(λ̂BABAM1, λ̂LMNA) = 0.69
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